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Abstract 
Mimosa pudica is a pan-tropical weed. It is used in Chinese medicine for 
analgesic and anti-inflammatory purposes. In Hong Kong the herb is often used to 
treat osteophyte. However, little effort has been made to evaluate its pharmacological 
effects. This project is designed to investigate its immunomodulatory values. 
Moreover, as the plant was recorded to have a mild toxicity, its toxicity was also 
assessed to ensure the safe use of this herb. I f this plant is shown to have 
pharmacological value, this may help turn a weed to human beneficial use. 
The Mimosa extract used in this study was the water extract of the whole 
plant. The dry plant material contained in each gram of extract, or dried weight 
equivalent (DWE) was 5.3. From the in vitro immunological studies, millipore-
filtered fraction of the water extract of M. pudica was found to have modulatory 
effect on both cellular and humoral immunities. It showed a significant stimulatory 
effect on splenocyte proliferation and a co-mitogenic effect with lipopolysaccharide 
(LPS) but not with concanavalin A (Con A). However, it did not show prominent 
effect on thymocyte proliferation. Moreover, the extract inhibited the thymocyte 
proliferation in the presence of Con A. Some of these findings could also be 
observed in the in vivo system. In mice fed with the extract for 10 days, the 
splenocyte proliferation was enhanced but the thymocyte proliferation was suppressed. 
Moreover, the mitogenic responses of splenocytes to both LPS and Con A and of 
thymocytes to Con A were enhanced. From the immunorestoration sturdy on 20-
week-old mice, it was noted the blastogenic response of the mice could be partially 
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restored by Mimosa extract. Besides the modulatory effects on lymphocytes, the 
extract could increase the phagocytosis of macrophages and reverse the inhibition 
caused by hydrocortisone. However, this effect could only be observed when the 
macrophages were cultured in the presence of the extract, but not for the 
macrophages cultured from the mice after daily oral administration of the extract for 
10 days. Besides, Mimosa extract inhibited the release of IL-1 by macrophages but 
enhanced the release by LPS-stimulated macrophages. The extract also activated the 
primary humoral immune response by increasing the release of haemolysin from 
antibody-forming-cells • 
For the toxicological studies, the results of acute and subacute toxicity tests 
indicated the water extract of M. pudica was practically non-toxic when taken orally. 
No mortality was observed in LD50 study by i.g. administration even at 15.0 g/kg 
(DWE = 79.5 g/kg). Similarly, no toxic symptom was observed in the subacute 
study at 10.0 g/kg/day (DWE = 53.0 g/kg/day) for 30 days. It also did not have any 
influence on early pregnancy at 3.75 g/rat/day (DWE = 19.9 g/rat/day) when 
administered orally for 10 days. However, when the extract was injected 
intraperitoneally, toxic symptoms of hindlimb paralysis and elevation of serum 
enzyme levels such as LDH, CK, GOT and GPT were observed. LD50 by i.p. 
injection for male and female mice were found to be 3.3土0.8 and 3.4±0.9 g/kg, 
respectively (DWE 二 17.5±4.2 and 18.0土4.8 g/kg). Apparently, the toxicity of 
Mimosa extract was greatly reduced when given through the gastro-intestinal tract. 
As a conclusion, the results of our present studies showed that Mimosa pudica 
vii 
had immunostimulatory effects. Although the potency was not high when the extract 
was given orally, its stimulatory effects may play a role in some of the traditional 
uses of this herb. 
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1.1 Objective and Scope of the Project 
Recently, many pharmaceutical research institutes are interested in higher 
plants as a source for new drugs (Hamburger and Hostettmann, 1991; Malone, 1983; 
Phillips, 1992). Plants used in traditional medicine are considered likely to yield 
pharmacologically active compounds. The World Health Organization (WHO) is also 
aware of the importance of herbal medicines for the health of many people throughout 
the world. Herbal medicines have been recognized as a valuable and readily available 
resource for primary health care, and WHO has endorsed their safe and effective use 
(WHO, 1993). Since the use of most herbal medicines is empirically, few of them 
have been subjected to scientific study. Therefore, scientific research on evaluating 
the efficacy and safety of herbal medicines should be encouraged (WHO, 1993). 
Mimosa pudica is a wide-spread plant and an inexpensive Chinese medicine. 
It is used as a herbal medicine in southern provinces of China. It was first recorded 
as a medicinal plant in Qing dynasty in Sheng Cao Yao Xin Bei Yao (He, 1711), 
according to which the plant had analgesic and anti-inflammatory effects. According 
to the Encyclopedia of Chinese Materia Medica (Anonymous, 1977), Mimosa pudica 
was recorded to have the value of cleaning the evil-heat, tranquillizing； relieving 
dyspepsia, and removing toxic material. It is used to treat enteritis, gastritis, 
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insomnia, infantile malnutrition, redness and swelling of eye, deep abscess and herpes 
zoster. In Hong Kong, many people take it to treat osteophyte (personal observation, 
unpublished). Although this plant is used in Chinese medicine, little effort has been 
made to evaluate its pharmacological effects. Traditionally, the guiding principle of 
Chinese medicine is to maintain the natural balance of the human body or to restore 
it to a balanced state during periods of illness, rather than a direct assault on the 
disease. Based on this concept, some people believe that many traditional medicines 
exert their effects by improving our immune system (Chihara, 1992; Labadie et al., 
1988). Therefore, this project is designed to investigate whether Mimosa pudica has 
any immunomodulatory effect which, i f present, may help offer rationale for the use 
of this herb in Chinese medicine. Moreover, Villarreal et al. (1991) reported that 
three different extracts of related species in the same genus, Mimosa tenuiflora, could 
modify the growth rate of normal embryonic fibroblasts and KB cells from a 
nasopharyngeal carcinoma in tissue culture conditions. It seems that Mimosa pudica 
may probably contain some components which also have immunomodulatory effects. 
On the other hand, as this plant was recorded to have a mild toxicity (Anonymous, 
1983)，its toxic effects are also studied in order to ensure the safe use of this herb. 
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1.2 Literature Review of Mimosa pudica 
1.2.1 Morphology of Mimosa pudica 
Mimosa pudica L . ( 含 羞 草 ； s e n s i t i v e plant) belongs to the family 
Leguminosae, subfamily Mimosoideae (Elias，1981). It is a scrambling shrubby plant 
growing to one meter high with branching stem (Figure 1.1). The plant is hairy and 
spiny. Leaves are alternate, bipinnatedly compound, and would fold and droop upon 
disturbance. Pinnae are usually four on each leaf, 4-7 cm long, digitately arranged 
at the apex of the main petiole, bearing 30-40 leaflets. Leaflets are linear-oblong, 
sessile, 8-13 mm long, short and sharp at the tip, with scattered spiny hair. 
Inflorescence is a globular capitulum with long stipe, single or 2 to 3 arising from the 
leaf axil, 1 cm in diameter. Flowers are pink and numerous. Calyx and corolla are 
minute; stamens are 4 in number, 3-5 mm long, exerted beyond the corolla. Fruit 
is a loment, flattened, slight curved, 1-2 cm long, composed of 3-5 one-seeded 
segments which disarticulate and fall apart when mature, leaving only the spinose-
bristly margins of the loment. Flowering season is in August but may be observed 
from June to September (Hou, 1956). 
M. pudica originally grows in tropical America but is now wide-spread as a 
pan-tropical weed (Good, 1964). It grows on the hillside, roadside, lawns and damp 
fertile pasture. It is found in eastern, southern and southwestern China. It is 
cultivated in temperate areas (eg. Inner Mongolia) as an ornamental plant 
(Anonymous, 1977). 
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Figure 1.1: A diagram showing a flowering branch of Mimosa pudica L. 
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1.2.2 Chemistry of Mimosa pudica 
The major chemical constituents of the whole plant of Mimosa pudica are 
flavonoid glycosides, phenols, amino acids and organic acids. It also contains 
mimosine (Notation and Spenser, 1964) and mimosine-o-B-D-glucoside (Murakoshi 
广 al., 1971). The leaves contain a kind of myosin-like contractile protein (Biswas 
and Bose, 1968)，which is involved in the movement of the leaves. Seeds were found 
to contain 7.4% of moisture, 25.7% of crude protein, 12.3% of pentosan, and 6.5% 
of hexane extractable oil. The defatted seed powder contained a mucilage which is 
a neutral polysaccharide (galactomannan). The mucilage contains 35.5% of galactan 
and negligible amount of pentoses (Farooqi et al., 1977). It is also found to have 
approximately 17% of oil. The fatty acids of the oil include 0.4% of linolenic acid, 
51% of linoleic acid, 31% of oleic acid, 8.7% of palmitic acid, and 8.9% of stearic 
acid. The seeds also contain 2.5% of unsaponifiable matter which contained two 
sterols (Aggarwal and Karimullah, 1945). Roots contain alkaloids, lactone substances 
and flavonoid glycoside (Anonymous, 1977). Mimosine present in the plant is a toxic 
amino acid. Its toxicity will be discussed in another section (section: 1.2.6). 
1.2.3 Uses in traditional medicine 
According to the Encyclopedia of Chinese Materia Medica (Anonymous, 
1977), Mimosa pudica tastes sweet and has cold properties. The whole plant has 
medicinal uses for cleaning away evil-heat, tranquillizing, relieving dyspepsia, and 
treating enteritis, gastritis, insomnia, redness and swelling of eye, infantile 
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malnutrition and inflammation. The root can be used as an expectorant and 
antitussive agent. Other literatures recorded that Mimosa pudica is used to treat 
neurasthenia, high fever in children, acute conjunctivitis, urolithiasis and 
rheumatalgia. It also has analgesic and diuretic effects. It can be used topically in 
traumatic injury, pyoderma and herpes zoster (Cheung and Li, 1981; Zhong Cao Yao 
Xue, 1976). 
In Southeast Asia, the water extract of roots is used to treat malaria, 
dysmenorrhoea and asthma, and to induce vomiting. Leaves are used in the treatment 
of swollen sore and pain while seeds are used in throat diseases (Cheung and Li, 
1981; Cheung, 1963). In Hong Kong, many people claim that the whole plant or root 
of M. pudica is effective in the treatment of osteophyte (personal observation, 
unpublished). 
1,2.4 Clinical and pharmacological studies of Mimosa pudica 
Although there are many uses of Mimosa pudica, very little pharmacological 
and clinical information can be found. Only one clinical study had been conducted 
on the treatment of 30 cases of chronic bronchitis of the aged people by using the root 
extract of the herb. After three courses of treatment (10 days for one course of 
treatment), 24 cases were satisfactorily controlled and 3 cases showed significant 
improvement (Anonymous, 1972). A compound prescription containing Mimosa 
pudica and Rubia cordifolia was also used to treat 86 patients of chronic bronchitis 
of the aged people; the results indicated a 95.4% efficiency after the first course of 
6 
treatment (Anonymous, 1972). 
Besides the clinical study, there were a few pharmacological studies on the 
water extract of the herb. They are summarized here: 
a) Expectorant and antitussive effects 
A study showed that the extract of the root of M. pudica had antitussive effect 
in mice; the whole plant and leaves had expectorant effect. The assay of using 
isolated intestinal segment indicated M. pudica had no spasmolytic effect 
(Anonymous, 1971). 
b) Effect on smooth muscle 
It was reported that the root extract did not show any dilation effect on 
isolated bronchus of guinea pig by perfusion study, but had significant anti-
acetylcholine effect on isolated ileum of rabbit (Anonymous, 1977). 
c) Effect on cardiovascular system 
In experiment using anaesthetized cat, it was found that intravenous injection 
of the root extract could steadily increase the blood pressure by 10-20 mmHg. It then 
returned to normal after 1 hour (Anonymous, 1971). 
d) Antibacterial effect 
A compound prescription containing the roots of Mimosa pudica and Rubia 
cordifolia showed a strong inhibitory effect on Diplococcus pneumoniae, 
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Streptococcus alpha, Staphylococcus aureus and influenza (Anonymous, 1971). 
e) Effect on urolithiasis 
Joyamma et al (1990) investigated the effect of M. pudica on treatment of 
urolithiasis. A model of urolithiasis was established by the implantation of zinc discs 
in urinary bladder of albino rats. It was found that the herb was not effective in 
either preventing stone deposition or dissolving preformed stones. 
Based on the traditional medicinal uses of Mimosa pudica, such as treating 
rheumatalgia and some inflammatory diseases, this herb seems to affect the immune 
system. Therefore, its immunomodulatory effects were examined in this study. As 
the crude extract usually contains only a small amount of the active constituents, 
highly sensitivity bioassays should be used (Hamburger and Hostettmann, 1991). In 
order to meet this requirement, immunological assays are chosen in this project. 
1.2.5 Toxicology of Mimosa pudica 
A toxicity study was reported on the water extract of the root of Mimosa 
pudica in a concentration of 0.5g plant material per ml (Anonymous, 1971). The 
result showed that the highest tolerance dose of the root extract in mice was 0.8 
ml/mice by intravenous injection. On the other hand, the highest tolerance dose of 
300% of the water extract of the whole plant was found to be 0.5 ml/mice by oral 
administration. The major toxicity symptom was the inhibition on nervous system. 
Oral administration of large doses could induce diarrhoea. Another study reported 
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that oral administration of 200 g/kg of the root extract to five mice, all mice showed 
reduction in activities and one had diarrhoea. No death was observed within 24 
hours. When the dosage was increased to 250 g/kg, the mice had diarrhoea and a 
significant reduction of activities. Two of the five mice died (Anonymous, 1977). 
As little toxicity information on the whole plant of M. pudica, this project will 
study the general acute and subacute toxicity of this herb. Its effect on fertility and 
pregnancy of rats was also investigated as the herb is said to be contraindicated in 
pregnancy (Anonymous, 1976, 1983; Cheung and Li, 1981). 
1.2.6 Characteristics and toxicology of mimosine 
In contrast to the few toxicity studies on Mimosa pudica, many studies had 
been carried out on mimosine, which is a toxic amino acid found in the legume 
genera Mimosa and Leucaena. The structure of mimosine is shown below: 
NH „ I 
Cli ,C11C00I1 I 
八 I 
0 
Mimosine forms dl-form crystal from water with melting point at 235-236 
It is slightly soluble in water (Ig in 500 ml at 25°C) (Lin and Ling, 1961a). It is 
much less soluble in methanol and ethanol, practically insoluble in the higher alcohols 
such as dioxane, ethylacetate, ether, benzene, chloroform, glacial acetic acid, pyridine 
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and cellosolve，but soluble in diluted acids or bases. The maximum UV absorption 
is at 282 nm (Budavari, 1989). 
Animals fed with a diet containing 0.5-1.0% of mimosine would result in 
growth retardation, shorten life span, alopecia (Lin and Ling, 1961)，cataract (Yang 
et aL, 1968; Von Sallmann and Grimes, 1959), hair loss (Crounse et al, 1962), 
infertility (Hylin and Lichton, 1965) and deformity of fetus (Dewreede and Way man, 
1970). However, Lin et al. (1964) demonstrated that addition of 1% of DL-
phenylalanine to the diet containing 0.5% of mimosine could reverse 37% of the 
growth inhibition caused by mimosine. Moreover, the growth retardation could be 
completely reversed by feeding the animals with 1% of L-tyrosine. Lin and Ling 
(1961b) found that protein and amino acids were present in the urine of the animals 
fed with the diet containing 0.5% of mimosine. Three possible mechanisms were 
suggested on the toxicity of mimosine: (1) antimetabolic effects on amino acid 
metabolism or protein biosynthesis as mimosine is structurally similar to 
phenylalanine and tyrosine (Lin et al.，1967; Lin et al.，1964); (2) mimosine forming 
a complex with pyridoxal phosphate which would then inhibit the activities of Bg-
requiring enzymes (Lin et al” 1962); and (3) mimosine acting as a chelating agent 
which would inhibit some metal-containing enzymes (Chang, 1960; Tsai, 1961; Lin 
and Tung, 1964). 
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1.3 Immunomodulation 
1.3.1 An overview of the immune system 
Our immune system defends ourselves against invasion by infectious agents, 
such as bacteria, viruses, fungi and other parasites, as well as spontaneously arising 
neoplasms. However, it is also responsible for hypersensitivity diseases and 
autoimmune diseases when there are defects in the immune system. Moreover, it 
plays a role in the rejection problems when organs or tissues are transplanted. 
The immune system is composed of several cell types (eg. phagocytes, 
lymphocytes, natural killer cells and mast cells) and many different kinds of soluble 
factors (eg. complements, lymphokines and interferons). All the cellular components 
of the system arise from haemopoietic stem cells, which are a unique group of 
unspecialized cells. The haemopoietic stem cells are present in the fetal liver or adult 
bone marrow. During development, the haemopoietic stem cells differentiate into 
different cell types: erythroids (erythrocytes), megakaryocytoids (platelets), myeloids 
(granulocytes and monocytes) and lymphoids (lymphocytes). The latter two, namely 
myeloids and lymphoids, are particularly important in the immune system. There are 
two types of lymphocytes, namely B cells and T cells. The maturation of most cells 
occur in bone marrow while T lymphocytes mature in the thymus. These organs are 
referred to as primary lymphoid organs. After maturation, the cells enter the 
circulation and recirculate through the secondary lymphoid tissues, including spleen, 
.lymph nodes, tonsils and gut-associated lymphoid tissues (Roitt et al, 1989), 
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The protective mechanisms of the immune system may be divided into two 
groups: the innate and adaptive immunities. The innate immunity includes 
mechanical barrier, soluble factors (eg. lysosomes and complements), and 
inflammatory cells (eg. phagocytes and natural killer cells). This innate resistance 
is nonspecific and indiscriminate. In contrast to the innate immunity, the adaptive 
immunity is specific and discriminate. The adaptive resistance can be improved by 
immunization. This immunity is carried out by the cooperation and interaction of the 
two immune responses: humoral- and cellular-mediated immune responses (Sell, 
1987). 
The humoral immunity involves the production of antibodies by B 
lymphocytes. After antigens are recognized by certain B lymphocytes, the B cells 
would begin to proliferate and differentiate into plasma cells which in turn produce 
a large amount of antibodies. These antibodies protect the host by binding to the 
antigens and hence facilitate the phagocytes to engulf the antibody-antigen complex. 
Moreover, the binding can activate the complement system and some other antibody-
dependent cellular cytotoxicity to destroy the antigens (Dean et al., 1989). 
The cellular immunity primarily involves T lymphocytes, where the helper T 
cells (Th) play the central role. After antigens are recognized and processed by 
antigen-presenting cells (APC) (eg. macrophages), the antigens are presented to the 
helper T cells which in turn help B cells to produce antibodies. Also, helper T cells 
can modulate the other effector cells, including cytotoxic T cells (Tc), natural killer 
cells (NK), macrophages, granulocytes, antibody-dependent cytotoxic cells (K) and 
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suppressor cells (Ts), by releasing different kinds of lymphokines. Besides, cytokines 
(eg. interleukins and tumor necrosis factor) released by macrophages also take an 
important part in these actions (Roitt et al., 1989). 
1-3.2 Strategies on the study of immunomodulation of Mimosa pudica 
Immunomodulation can be defined as any type of therapeutic intervention 
aimed at restoring the normal function of the immune system. Immunomodulators 
are drugs that directly modify a specific immune function or have a net positive effect 
(immunostimulation) or a net negative effect (immunosuppression) on the activity of 
the immune system. The potential uses of immunomodulators in clinical medicine 
include the reconstitution of immune deficiency and the suppression of normal or 
excessive immune functions such as in the treatment of graft rejection or autoimmune 
diseases (Goust et al., 1990; Jaffe and Sherwin, 1991). 
It is a worldwide interest in searching for potential drugs which have 
immunostimulatory or immunomodulatory effects (Labadie et al., 1988; Chihara, 
1992). Although the indication 'immunodeficiency' cannot be found in traditional 
medicine, it is obvious that traditional medicines contain a large amount of drugs 
which from ancient times had been used successfully against infections, cancer, and 
various chronic diseases. Therefore, it is reasonable to select those plant drugs which 
have antimicrobial, antiviral and antitumour activities for studying their 
immunomodulatory activities (Wagner, 1985; Wagner and Jurcic, 1991). From 
folkloric records and current experimental studies (Anonymous, 1977), it appeared 
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that Mimosa pudica had some antibacterial, antiviral and anti-inflammatory effects, 
and it was therefore selected in this study to determine if it had immunomodulatory 
effects. Some assays were selected to measure its influence on the phagocytic 
system, the T- and B-lymphocytes, and the secretion of some soluble factors. These 
assays include lymphocyte proliferation, phagocytic capability of macrophages, 
secretion of interleukin 1 (IL-1) by macrophages and secretion of immunoglobulin M 
(IgM) by B cells. The principles of these assays are summarized as follows: 
a) Lymphocyte proliferation 
Lymphocyte proliferation or transformation is the process in which T or B 
lymphocytes undergo new DNA synthesis and cell division in response to a given 
stimulus. The commonly used stimulants are mitogens such as phytohaemagglutinin 
(PHA), concanavalin A (Con A) and lipopolysaccharide (LPS), which are non-specific 
polyclonal activators. Mitogen-induced proliferation, unlike specific antigens, does 
not require previous exposure, and can be used to assess the responsiveness of T or 
B lymphocyte populations as a whole. Mitogens activate lymphocytes by binding to 
surface receptors which are present on almost all lymphocytes of a given type. 
Different mitogens can selectively activate T or B cell populations (Ashman, 1984; 
Miller et al, 1991; Greaves and Janossy, 1972). 
Lymphocyte proliferation is performed by in vitro culturing of a lymphocyte 
population in the presence or absence of a selected stimulus for a period of time. 
During incubation, the stimulated lymphocytes are transformed into large： blast-like 
cells that undergo DNA synthesis and mitosis. Evaluation of lymphocyte 
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transformation can be quantitated by determination of the increased DNA synthesis, 
which in turn can be detected by the incorporation of a radiolabeled DNA precursor, 
eg. ^H-thymidine, and expressed in counts per minute (cpm) (Miller et al., 1991). 
b) Phagocytic activity of macrophages 
Acute inflammation in the peritoneal cavity can be induced by the i.p. 
injection of thioglycollate. After 72 hours, peritoneal cellular exudates which are 
predominantly composed of macrophages can be obtained (Gervais et al，1984). The 
phagocytosis may be analyzed quantitatively by measuring the accumulation of 
particles within the macrophages (Southewick and Stossel, 1986). 
Glucocorticoids are potent immunosuppressive agents. They have inhibitory 
effect on the phagocytosis of macrophages (Grasso et al., 1981; Wiener and 
Marmary, 1969; Parrillo and Fauci, 1979). Therefore, hydrocortisone is used as a 
positive control in this assay to study the effect of Mimosa pudica on the phagocytic 
activity of macrophages in the presence of hydrocortisone. 
c) Release of interleukin 1 (IL-1) by macrophages 
IL-1 plays an important role in inflammation and many immune responses. 
It is produced by a range of cell types, predominantly monocytes and macrophages 
(Ward et al., 1988) which are induced to released IL-1 following the uptake of 
antigen-antibody complexes or LPS (Pignol et al., 1989). Since IL-1 can promote 
the growth of T lymphocytes, thymocyte proliferation can be used as an index for IL-
1 release by macrophages (Yang and Li, 1989; Ward et al., 1988; Snyder and 
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Unanue, 1982). 
d) Plaque forming cell (PFC) 
Antibody production is one of the major lymphocyte effector functions. The 
antibody-producing cells are measured by plaque forming cell assay. By modifying 
the plaque forming cell assay, it is possible to separatively identify different classes 
of immunoglobulins, as well as to identify the total number of antibody-producing 
cells (Steward and Male, 1989). Antibody-forming cells can be measured 
quantitatively by mixing the test population with antigen sensitized red cells. The red 
cells that surrounding the specific antibody-secreting cells would be coated with the 
haemolysin and then lysed by complement. Therefore, the amount of antibody-
secreting cells and the amount of antibodies that released can be determined by the 
degree of haemolysis of red cells (Simpson and Gozzo, 1978). 
e) Immunorestoration on splenocyte blastogenesis of old mice 
It has been known that decay of the immune system is accompanied with the 
aging process. The high susceptibility of aged people to infectious diseases is closely 
related to the decline of immune response (Antonaci et al.，1987; Kim et al.，1985). 
I f Mimosa pudica can enhance the immune system, it is interesting to see whether it 
can also restore the declined immune response in the old animals. As a preliminary 
study, the assay of lymphocyte proliferation was chosen to investigate the effect of 
the Mimosa extract on the cellular immunity of the old animals. 
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1.4 Toxicology 
Toxicology involves the study of the adverse effects of chemicals on living 
systems in order to predict chemical hazard to man. This study helps in defining 
possible toxicity from short-term use, but is particularly important in detecting 
toxicity that may occur either after prolonged exposure or years after the exposure 
has been discontinued (Anderson and Conning, 1988; WHO, 1993). 
1.4.1 Principles of the toxicological assays 
1.4.1.1 LD50 
Acute toxicity has been defined by the Organization for Economic Cooperation 
and Development (OECD) as "the adverse effects occurring within a short time of 
administration of a single dose of a substance or multiple doses given within 24 
hours". The determination of the median lethal dose (LD50) of a compound is the 
most frequently used acute toxicity test. LD50 is the dose of a compound that causes 
50% mortality in a population. OECD panel of experts defined LD50 as the 
"statistically derived single dose of a substance that can be expected to cause death 
in 50% of the animals" (Chan and Hayes, 1989). Although many critics criticize that 
LD50 has limited significance in predicting safety or toxicity in man, preliminary 
lethality data are required to plan a more extensive toxicity study. Moreover, LD50 
can provide a measure of relative toxicity which allows the tested substance, 
especially new compounds, to be evaluated and allocated to a particular class of 
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toxicity (Table 1.1) (Pascoe, 1983; Gad and Chengelis, 1988). 
Table 1.1: Classification of toxicity (Pascoe, 1983) 
LD50 (mg/kg) Classification 
< 5 super-toxic 
5-50 extremely toxic 
50-500 very toxic 
500-5000 moderately toxic 
5000-15000 slightly toxic 
> 15000 practically non-toxic 
1.4.1.2 Enzyme assays 
Enzymes are proteins that act as biological catalysts, which are always highly 
specific for particular types of biochemical reactions, by altering the rate and 
providing a means of regulation of metabolism. Their activities are subject to the 
influence of many variables including the temperature and pH of their environment, 
the supply of reacting materials, the removal of reaction products, and the presence 
of activators or inhibitors (Walmsley and White, 1988; Wilkinson, 1976). 
Although a great diversity of enzymes are found in the tissues and fluids of 
the body, only a few are routinely studied for clinical diagnosis. Since enzymes are 
primarily intracellular, the presence of increased amounts of an enzyme in serum or 
plasma is generally a consequence of cell injury that allows the escape of intracellular 
molecules. Therefore, abnormal elevation of enzymes in serum can be used as an 
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evidence of cell or organ damage. Enzymes released into the blood circulation have 
no physiological function and are gradually removed by normal routes of excretion 
(Sacher et al, 1991). 
Some most commonly used enzymes have a widespread distribution in most 
. body tissues; an increased activity of these enzymes would result in a number of 
diseases. On the other hand, some enzymes are organ-specific or occur in different 
forms eg. isoenzymes, according to the tissue from which they are derived. The 
measurement of such appropriate plasma enzyme activities can yield organ-specific 
diagnostic information. Although many commonly used enzymes are non-specific, 
the pattern of their increase may give some information in diagnosis, or combine with 
clinical findings to indicate the organs involved (Walmsley and White, 1988; 
McLauchlan, 1988). 
Five of the commonly used enzymes are selected here to study the general 
toxicity of Mimosa pudica. Their properties are summarized as follows: 
a) Lactate dehydrogenase (LDH) 
Lactate dehydrogenase (LDH) is a hydrogen transfer enzyme which catalyses 
the reversible oxidation of L-lactate to pyruvate with the mediation of L-NAD as a 
hydrogen acceptor. 
LDH 
CH3.CHOH.COO- + NAD+ < > CH3.CO.COO- + NADH + H+ 
lactate pyruvate 
LDH is a zinc-containing enzyme, present in almost all the tissues of the body 
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and located only in the cytoplasm of the cell. Intracellular enzyme level is many 
folds higher than in the serum. Therefore, a significant elevation of LDH in serum 
level can be observed even though there is only a small extent of tissue damage 
(Kachmar and Moss, 1976). The principal sources of LDH are heart, liver, skeletal 
musde，kidney, erythrocytes, pancreas and lung. Thus, LDH activity may be 
significantly elevated in some diseases such as myocardial diseases, liver diseases, 
skeletal muscle diseases, renal diseases and haematological disorders (Walmsley and 
White, 1988). 
The principle for the determination of LDH activity is based on the fact that, 
during reduction of pyruvate, an equimolar amount of NADH is oxidized to NAD. 
The oxidation of NADH is monitored continuously by measuring the rate of 
absorbance decrease at 340 nm in a spectrophotometer. The rate of decrease is 
directly proportional to LDH activity in the sample (McLauchlan, 1988). The 
detailed procedure is referred to Appendix I. 
b) Creatine kinase (CK) 
Creatine kinase (CK), also referred to as creatine phosphokinase or creatine 
phosphotransferase, catalyses the reversible phosphorylation of creatine by adenosine 
triphosphate (ATP). 
adenosine triphosphate (ATP) CK adenosine diphosphate (ADP) + < > + 
creatine creatine phosphate 
Mg2+ is an obligate activating ion which exists in the form of its -salts with 
ADP and ATP. CK is found in highest activity in skeletal muscle, heart muscle and 
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brain tissue. The determination of CK activity has proved to be much more sensitive 
than many other laboratory tests in the investigation of skeletal muscle diseases, and 
is also useful in the diagnosis of myocardial infarction and cerebrovascular accidents 
(Kachmar and Moss, 1976). 
The colorimetric method used to determine the CK activity is recommended 
by the German Society for Clinical Chemistry (1977). The series of linked reactions 
involved in the assay procedure are as follows: 
CK 
creatine phosphate + ADP > creatine + ATP 
hexokinase 
ATP + glucose > ADP + glucose-6-phosphate 
G-6-PDH 
G-6-P + NADP > 6-phosphogluconate + NADPH + H+ 
ATP formed from creatine phosphate and ADP by the action of CK reacts 
with glucose in the presence of hexokinase to form glucose-6-phosphate (G-6-P). 
Subsequently, G-6-P is oxidized by NADP in the presence of glucose-6-phosphate 
dehydrogenase (G-6-PDH) to form 6-phosphogluconate and NADPH. The rate of 
increase in absorbance at 340 nm due to the formation of NADPH is directly 
proportional to CK activity as CK catalysed reaction is the rate-limiting step. The 
detailed procedure for the determination of CK activity is referred to Appendix I I . . 
c) Aspartate aminotransferase (AST) / Glutamic oxalacetic transaminase (GOT) and 
Alanine aminotransferase (ALT) / Glutamic pyruvic transaminase (GPT) 
Aminotransferases or transaminases constitute a group of enzymes which 
catalyse the process of transferring an amino group from an a-keto acid. As a result, 
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a different a-amino acid and a different a-keto acid are formed. Transamination 
plays a key role in intermediate metabolism as it takes part in the synthesis and 
degradation of amino acids in living cells. The three amino acids, glutamate, 
aspartate and alanine, are converted into corresponding ce-keto acids which are the 
components of the tricarboxylic acid cycle. Thus, they are oxidized to provide a 
source of energy. Moreover, transamination is also involved in providing aspartate 
for the urea cycle (Wilkinson, 1976). Aminotransferases require pyridoxal-5,-
phosphate (vitamin Bg) as a co-factor which mediates amino group transfer and forms 
pyridoxamine derivatives (Sacher et al,, 1991). Two clinically important 
aminotransferases are aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT). These two enzymes are also known as GOT and GPT, respectively. They 
catalyse the following reactions: 
GOT 
aspartic acid + a-ketoglutaric acid > oxalacetic acid + glutamic acid 
GPT 
alanine + a-ketoglutaric acid > pyruvic acid + glutamic acid 
GOT is widely distributed in body tissues, heart, liver, skeletal muscle and 
kidney being the richest sources. Smaller amounts are also present in pancreas, 
spleen, lung and erythrocytes. On the other hand, liver is the major source of GPT 
while heart, skeletal muscle and kidney are the minor sources. As the two 
aminotransferases can be found in large amounts in the liver, they have been widely 
used for diagnostic purposes of liver damage. GOT is present in both the 
mitochondria and cytosol of liver cells, whilst GPT is found in the cytosoL Damaged 
hepatocytes release these enzymes into extracellular fluid and result in elevation of 
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serum levels of aminotransferase activity. Usually, GPT level is greater than that of 
GOT in hepatitis. However, i f GOT is found to be greater than that of GPT, it 
suggests that there is a widespread of hepatitic necrosis as the mitochondrial enzymes 
are released. Thus, the relative activities of these two enzymes can provide some 
information on the underlying pathology and severity of the disease processes 
(Walmsley and White, 1988). 
The method for the determination of GOT and GPT is generally based on 
those described by Reitman and Frankel (1957). The oxalacetic or pyruvic acid 
formed in the GOT or GPT catalysed reactions can react with 2,4-
dinitrophenylhydrazine to form a coloured product of phenylhydrazones. The colour 
intensity of this product is proportional to the transaminase activity. Although the a-
ketoglutaric acid in the substrate mixture, as well as the keto acids produced by 
transamination, would form coloured hydrazones, the hydrazones formed from the 
reaction products of oxalacetic or pyruvic acid are more chromogenic and possess 
different spectral absorption maxima than that of of-ketoglutaric acid. Therefore, this 
colorimetric measurement of the enzyme activity is still feasible and being commonly 
used. The detailed procedures of GOT and GPT assays are referred to Appendix I I I 
and IV respectively. 
d) Alkaline phosphatase (ALP) 
Alkaline phosphatases (ALP) are a group of relatively non-specific enzymes 
which hydrolyse a variety of ester orthophosphates under alkaline conditions. Mg2+ 
and Zn2+ are the activators of ALP; an optimal Mg2+/Zn2+ ratio is required for its 
23 
maximum activity (McLauchlan, 1988). 
The enzyme is present in almost all tissues of the body, the richest sources 
being intestinal mucosa, osteoblasts of bone, bile canaliculi of liver, proximal tubules 
of kidney, placenta and lactating mammary glands. In all these sites, ALP activity 
is localized at the cell membrane. Therefore, ALP appears to be involved in the 
transport mechanisms of phosphate as active transport is the important function in 
these tissues. ALP activity is useful in diagnosing hepatobiliary diseases and bone 
disorders associated with increased osteoblastic activity (McLanchlan, 1988). 
The principle for the determination of ALP activity is according to its ability 
to catalyse the following reaction: 
ALP 
p-Nitrophenyl phosphate + HjO > p-Nitrophenol + phosphate 
Para-nitrophenylphosphate (PNPP) is colourless. ALP splits off the phosphate 
group of PNPP to form free p-nitrophenol, which is converted to the p-nitrophenoxide 
ion in alkaline conditions and shows an intense yellow colour with an absorbance 
maximum at 405 nm. Thus, the rate of increase in absorbance is directly 
proportional to ALP activity in the serum (Bowers and McComb, 1966). The 
detailed procedure is referred to Appendix V. 
1.4.1.3 Subacute toxicity test 
Subacute toxicity studies are designed to examine the adverse effects on an 
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experimental animal resulting from repeated exposure to the test substance over a 
period of time. A compound shown to be non-toxic in acute toxicity test may be 
toxic after prolonged exposure, even at low doses, due to accumulation, changes in 
enzyme levels, and disruption of physiological and biochemical homeostasis. 
Therefore, subacute studies can provide information on the cumulative toxicity of a 
substance on target organs and on physiological and metabolic tolerance of a 
compound after prolonged exposure. It also aids in selecting doses for chronic, 
reproductive, and carcinogenicity studies (Mosberg and Hayes, 1989). Some of the 
physical examinations (eg. body weight and organ weights), biochemical examinations 
(eg. enzyme assays), and pathological examinations (eg. microscopic histology) can 
be conducted to assess the effects of a test substance on the animals (Loomis, 1978). 
1.4.1.4 Reproductive toxicity test 
The mammalian reproductive process is long and complex, and thus 
susceptible to influence by exogenous agents. It is known that many foreign 
compounds can induce developmental abnormalities in the embryo or fetus. Some 
investigations are designed for evaluating chemical injury to reproductive function in 
experimental animals. The approach commonly adopted is the use of a three segment 
scheme of studies. The，Segment 1，study is designed to assess the toxic effect of a 
substance on gonadal function and mating behaviour in both male and female animals. 
In addition, the effects on conception rate, the early and late stages of gestation, 
parturition, lactation, and the development of offspring are assessed. The: 'Segment 
2，study is conducted to evaluate the teratogenic potential of a test compound. 
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Female animals only are treated with the test compound post-mating and during the 
period of major organogenesis. The 'Segment 3' study is used to assess the effects 
of a substance on the peri- and post-natal development of fetus (Gangolli and Phillips, 
1988). Since Mimosa pudica is recorded to be contraindicated in pregnancy (Cheung 
and Li , 1981),，Segment 2’ study is adopted to evaluate its effects on implantation 
and pregnancy. The employed assay is a preliminary test aimed at determining if the 
Mimosa extract has any effect on the first 10 days of pregnancy in the rat so as to 




Materials and Methods 
2.1 Materials 
2.1.1 Mimosa pudica 
Whole plants of Mimosa pudica, including flowers and seeds, were collected 
in Hong Kong (the campus of The Chinese University of Hong Kong) from June to 
September, 1991. The botanical identity of the plant material was verified by Dr. 
Paul P. H. But and the voucher specimens (Cheng 1-4) were deposited in the 
Herbarium, Biology Department, CUHK. Samples were cut into small pieces and 
dried for storage. 
2.1.2 Animals 
BALB/c An (6-8-week-old), C57BL/6N (6-8-week-old) and ICR (4-6-week-
old) male or female mice, Sprague-Dawley male or female rats (180-220g), Sprague-
Dawley pregnant rats (220 ± lOg) and Dunkin-Hartley male guinea pigs (3 month-old) 
were supplied from the Animal House, The Chinese University of Hong Kong. They 
were fed with animal diet (Rodent Laboratory Diet 5001 for mice and rats, Guinea Pig Diet 5025 for guinea pigs, Purina Mills，U.S.A.) ad libitum with free access to 




Normal saline was prepared by dissolving 0.9g sodium chloride (NaCl) (Ajax, 
Australia, analytical grade) in 100 ml distilled water. 
Phosphate-Buffered-Saline rPRS^ 
PBS was prepared by dissolving 1.48g disodium hydrogen phosphate 
(Na2HP04) (Ajax, Australia, analytical grade), 0.43g potassium dihydrogen phosphate 
(KH2PO4) (Ajax, Australia, analytical grade) and 6.8g NaCl in I L of double-distilled 
water. The solution was adjusted to pH 7.2 by IM sodium hydroxide (NaOH) or I M 
hydrochloric acid (HCl), and was sterilized by autoclaving at 121 °C for 20 minutes. 
Penicillin-Streptomycin (PS) 
Penicillin-Streptomycin was purchased from GIBCO (U.S.A.). The antibiotics 
solution was separated into 5 ml aliquots and stored at -20°C. 
Fetal Bovine Serum (TBS) 
FBS was purchased from GIBCO (U.S.A.). The serum was separated into 20 
ml aliquots and stored at -20°C. 
RPMI culture medium 
RPMI 1640 medium (GIBCO, U.S.A.) was prepared by dissolving 1 litre-
powder package and 0.87g sodium hydrogen bicarbonate (NaHCO�）(Ajax, Australia, 
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analytical grade) in I L double-distilled water. The solution was adjusted to pH 7.2 
by I M NaOH or I M HCl. It was sterilized by 0.2 /^ m millipore filtration. The 
medium was supplemented with 100 units/ml of penicillin G sodium, 100 /xg/ml 
streptomycin sulfate (GIBCO, U.S.A.) and 10% fetal bovine serum (GIBCO, 
U.S.A.), hereafter referred to as "complete culture medium". 
Mitogens 
Stock solutions of concanavalin A (Con A) and lipopolysaccharide (LPS) 
(Sigma, U.S.A.) were prepared by dissolving the chemicals into PBS to make the 
concentration of 100 jixg/100 /al. They were sterilized by 0.2 fxm millipore filtration 
and stored at -20 
Trypan blue solution 
0.2% solution of trypan blue (Sigma, U.S.A.) was prepared by dissolving the 
powder in PBS solution. 
Neutral red solution 
0.1% solution of neutral red (Sigma, U.S.A.) was prepared by dissolving the 
powder in saline solution. 
Methyl-^H Thymidine r^H-TdR) 
0.5 mCi/ml solution of ^H-thymidine (2 Ci/mmol, Amersham, U.K.) was 
prepared by diluting the stock solution with RPMI 1640 medium. 
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Thioglvcollate 
3% thioglycollate (DIFCO, U.S.A.) in PBS was prepared and sterilized by 
autoclaving at 121°C for 20 minutes. 
Sheep Red Blood Cell rSRBn 
SRBC was purchased from SEROTEC (U.K.) and was washed by PBS for 
several times before used. 
Hydrocortisone (UC) 
Stock solution of lO'-'^ M of hydrocortisone (Sigma, U.S.A.) in RPMI 1640 
medium was prepared and sterilized by 0.2 ixm millipore filtration. Different 
molarities were made by RPMI dilution. 
Mimosine 
Mimosine was purchased from Sigma (U.S.A.) and was suspended in normal 
saline when administered to mice. 
Scintillation fluid 
Scintillation fluid was prepared by dissolving 15g of 2,5-diphenyloxazole 
(PPO) and 0.125g of dimethyl-1,4-bis (2-(5-phenyloxazol)) benzene (POPOP), both 
from Sigma (U.S.A.), in 2.5L of toluene (Merck, Germany, scintillation grade) and 
stirred overnight to dissolve the compounds completely. 
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Lytic solution 
Lytic solution was prepared by mixing glacial acetic acid (Peking, China, 
analytical grade) and absolute alcohol (Merck, Germany, GR grade) in 1:1 ratio. 
Guinea pig complement 
Blood from adult guinea pig was obtained by heart puncture and serum was 
isolated for performing the plaque-forming-cells assay. Before the assay, 1 ml of 
undiluted serum was mixed with 0.2 ml packed SRBC at 4。C for 30 minutes in order 
to remove any non-specific complement-mediated haemolysin. The absorbed 
complement was recovered by centrifuging at 3,000 rpm for 10 minutes and made a 
1:20 dilution by PBS. 
Enzyme Kits 
Kits of lactate dehydrogenase (DG1340-K), creatine kinase (DG147-K), 
aspartate aminotransferase/alanine aminotransferase (505-OP) and alkaline 




2.2.1 Extraction of Mimosa pudica 
In every extraction, 50g whole plant dry material were cut into small pieces 
and soaked in 2 litres of distilled water for 1 hour, and then boiled for 1 hour. After 
boiling，the extract was filtered by a gauze to separate it from the plant material. The 
extract was saved and the plant material was added with another 2 litres of distilled 
water and boiled for 1 hour. The second extract was also obtained by filtering 
through a gauze. The two water extracts were pooled together and concentrated to 
a smaller volume («200 ml) by evaporation. Afterwards, it was centrifuged at 3,000 
rpm for 10 minutes to remove the large particles and impurities. Finally, the water 
extract was lyophilized into dry powder for storage in desiccator (Figure 2.1). A 
total of 3 kg dry plant material was extracted to obtain a total yield of 567.9g dry 
powder (Dry Weight Equivalent (DWE) = 5.3g dry plant material per g of extract). 
The extract is hereafter referred to as the Mimosa extract. 
a) Preparation of the extract for cell culture: 
A stock solution was prepared by dissolving the powder extract of Mimosa 
pudica in RPMI medium to make a concentration of 20 mg powder/ml and was stored 
at -20°C. It was defrost and made a 5-fold dilution by RPMI medium. Then it was 
sterilized by 0.45 /xm millipore filtration and was ready for cell culture. 
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b) Preparation of the extract for oral administration or intraperitoneal injection: 
The powder extract was dissolved in saline or distilled water according to 
different dosages in the experiment. 
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50g dry plant material was soaked 
in 2L of distilled water for 1 hr 
Boiled for 1 hr 
Filtered by a gauze 
Residue was added with Extract 1 
another 2L of distilled water 
•4/ 
Boiled for 1 hr 
�f 
Filtered by a gauze 
、‘ ^ 
Discarded residue Extract 2 
、梦 
Pooled two extracts together 
Concentrated the extract to «200 ml by evaporation 
•y 
Centrifugation at 3,000 rpm for 10 minutes 
Supernatant Discarded precipitate 
lyophilization 
Powder of water extract 
stored in desiccator 
Figure 2.1: Flow chart showing the extraction of Mimosa pudica. 
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2.2.2 Assays for the immunomodulatory effects of Mimosa pudica 
2.2.2.1 Cell preparation 
a) Splenocytes 
Four to Five mice were sacrificed by cervical dislocation. Their spleens were 
removed aseptically and pooled together in RPMI 1640 medium. Isolated cells were 
obtained by teasing the spleens through a sterile sieve in RPMI medium with a 
plunger of plastic syringe. The splenocytes were washed 2 times with RPMI medium 
by centrifuging at 1,500 rpm for 10 minutes. The cell pellet was resuspended in 20% 
FBS. The cell number was counted by preparing a 10-fold dilution of 1 % acetic acid 
which was used to lyse the RBC. After a few minutes, the cells were counted by 
using a haemocytometer. The viability of the cell suspension was over 95% by 
trypan blue exclusion test (Hudson and Hay, 1976). The cell suspension was adjusted 
to a concentration of 5X10^ cells/ml by adding 20% FBS and was ready for cell 
culture. 
b) Thymocytes 
Preparation of thymocyte cell suspension was similar to that of splenocytes 
(section: 2.2.2.1a). Mice were sacrificed and their thymuses were removed. Isolated 
thymocytes were obtained and washed 2 times by RPMI medium. The cell pellet was 
resuspended in 20% FBS. The cell number was counted by preparing a 10-fold 
dilution of 1% acetic acid. The viability of the cell suspension was over 95% by 
trypan blue exclusion test (Hudson and Hay, 1976). The thymocyte concentration 
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was adjusted to 1X10? cells/ml by 20% FBS and was ready for cell culture, 
c) Macrophages 
The method from Gu et al, (1990) was followed with some modifications. 
Five to six mice were administered with 3 ml of 3% thioglycollate per mouse by 
intraperitoneal injection to induce the peritoneal exudate cells (PEC). After 3 days, 
the mice were sacrificed by cervical dislocation and their abdominal skins were 
removed aseptically. The peritoneal cavity was lavaged by injecting 5-6 ml of PBS 
through a 19-G needle. After lavaging for about 1 minute, the peritoneal fluid was 
collected by the needle, and the lavaging process was repeated once. All the 
peritoneal fluids from the mice were pooled together and washed by centrifuging at 
1,500 rpm for 5 minutes. The cell pellet was resuspended in 10% FBS. The cell 
number was counted and adjusted to 2X10^ cells/ml. The viability of the cell 
suspension was over 95 % when checked by trypan blue exclusion test (Hudson and 
Hay, 1976). Then 0.1 ml of the cell suspension was added into each well of 96-well 
flat-bottomed microtitre plate (Nunc, Denmark). The plate was incubated at 37°C 
in a humidified atmosphere containing 5% CO2 in air for 2 hours. After incubation, 
the non-adherent cells and the medium were discarded. The macrophages adhered 
at the bottom of the plate was washed by warm PBS for 2 times. Finally, 0.1 ml 
20% FBS was added to each well and was ready for cell culture. 
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2.2.2.2 Splenocyte proliferation 
a) In vitro study: 
The method from Leung et al. (1986) was followed with some modifications. 
Splenocyte suspension from C57BL/6N mice was prepared and adjusted to 5X10^ 
cells/ml (section: 2.2.2. la). 100 of the suspension was added to each well of a 96-
well microtitre plate. Different concentrations of Mimosa extract and/or mitogens 
were added to make a final volume of 0.2 ml/well. Two mitogens, LPS and Con A 
were used in their sub-optimal concentrations of 10 /xg/ml and 1 /zg/ml，respectively. 
The plate was incubated at 37°C in a humidified atmosphere containing 5% CO2 in 
air for 48 hours. After 42 hours of incubation, 50 /xl of 0.5 /xCi ^H-thymidine was 
added to each well and further incubated for 6 hours. Then the cells were harvested 
onto a glass fibre filter (Flow Lab, U.K.) by a Titertek cell multiharvester (Flow Lab, 
U.K.). The radioactivity incorporated into the cells was counted by a liquid 
scintillation counter (Beckman LSI801，U.S. A.). The DNA synthesis was determined 
by ^H-TdR incorporation and was expressed in counts per minute (cpm). Usually, 
each sample was done in quadruplication. 
b) In vivo study: 
BALB/c An male mice in groups of four were fed with different dosages of 
the Mimosa extract (2.5，5.0 or 10.0 g/kg/day; DWE =13.3，26.5 or 53.0 g/kg/day) 
in saline by stomach tube. The control group was fed with the same volume of 
saline. After feeding continuously for 10 days, the mice were sacrificed and the 
splenocyte suspensions were prepared as mentioned in section 2.2.2.1a. Then the in 
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v/w study of the mitogenic effect of Mimosa extract was determined as the in vitro 
assay except no further Mimosa extract was added to the culture. Also, the weight 
of the spleens was measured. 
2.2.2.3 Thymocyte proliferation ^ 
a) In vitro study: 
The method from Ward et al (1988) was followed with slight modifications. 
Thymocytes from C57BL/6N mice was prepared and cultured in RPMI complete 
culture medium which containing 20% of FBS in a 96-well microtitre plate with 100 
jul per well (section: 2.2.2.1b). Different concentrations of Mimosa extract and/or 
mitogen Con A were added to make a final volume of 200 per well. The plate was 
incubated at 37°C in a humidified atmosphere containing 5% CO2 in air for 72 hours. 
The culture was pulsed with 50 yil of 0.5 /xCi/well of ^H-thymidine 8 hours before 
cell harvesting with a Titertek cell multiharvester (Flow Lab, U.K.). The cell 
proliferation was determined by measuring the amount of incorporated ^H-TdR by 
liquid scintillation and expressed in cpm. Usually, each sample was done in 
quadruplication. 
b) In vivo study: 
Thymocyte preparation and the in vivo assay were the same as that in 
splenocytes (section: 2.2.2.1b and 2.2.2.2). Then the thymocyte culture for 
determining the mitogenic effect of Mimosa extract was the same as the in vitro assay 
except no further Mimosa extract was added. Also, the weight of the thymuses was 
38 
measured. 
2.2.2.4 Phagocytic activity of macrophages 
a) In vitro study: 
The phagocytosis was measured by using spectrophotometrical method as 
mentioned by Wang et al (1987) and Gu et al. (1990). Macrophages from 
C57BL/6N mice was prepared (section: 2.2.2.1c) and each well of a 96-well 
microtitre plate contained 100 pX of the cells. Different concentrations of Mimosa 
extract and/or hydrocortisone were added to make a final volume of 200 yiX per well. 
The plate was incubated at SVC in a humidified atmosphere containing 5% CO2 in 
air for 24 hours. After incubation, the drugs were discarded and the cells were 
washed by warm PBS for 2 times. Then 0.1% of prewarmed neutral red solution was 
added with 50 /xl/well and the incubation was continued for 30 minutes. After that, 
excess neutral red solution was discarded and the cells were washed by warm PBS 
for 2 times. The plate was dried in a 60°C oven for 1 hour. 200 /xl of lytic solution 
was added to each well and the plate was left overnight. The macrophages were 
lysed to release the engulfed neutral red solution which was measured by microplate 
reader at O.D. 540 nm (BIORAD 3550, U.S.A.). The amount of neutral red uptake 
by macrophages was determined from a standard curve which was constructed by 
different concentrations of neutral red solution (Appendix, Figure A1). Usually, each 
sample was done in quadruplication. 
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b) In vivo study: 
BALB/c An male mice in groups of four were administered by intragastrical 
administration with different dosages of Mimosa extract (2.5，5.0 or 10.0 g/kg/day; 
DWE = 13.3, 26.5 or 53.0 g/kg/day) in saline for 10 days. Control group was fed 
with the same volume of saline. 3 days prior to the end of drug administration, 3 ml 
of 3% thioglycollate was injected intraperitoneally to each mice. After feeding 
continuously for 10 days, the mice were sacrificed and the macrophages were 
prepared as mentioned in section 2.2.2.1c. The phagocytic assay was performed as 
the in vitro study except no further Mimosa extract was needed. 
2.2.2.5 Release of IL-1 by macrophages 
a) Preparation of macrophages: 
The method from Kurakata et al. (1991) was followed with slight 
modifications. Peritoneal exudate cells (PEC) were obtained from C57BL/6N mice 
and macrophages were purified in the same way as mentioned before 
(section:2.2.2.1c) except that the PEC were adjusted to 1.5X10^ cells/ml and added 
at 1.0 ml per well to a 24-well flat-bottomed plate (Dune, Denmark). After 
macrophages purification, non-adherent cells were discarded and 0.9 ml complete 
culture medium containing 10% FBS was added. Different concentrations of Mimosa 
extract in the presence or absence of 10 jL^g/ml LPS were added and incubated at 
37°C in a humidified atmosphere containing 5% CO2 in air for 24 hours. Then, the 
supernatants were collected and centrifuged at 2,000 rpm for 10 minutes to remove 
any non-adherent cells. The cell-free supernatants containing IL-1 were distributed 
40 
into aliquots and stored frozen at -20°C. 
b) IL-1 Assay: 
Supernatants of macrophage culture were determined for their IL-1 activities 
by using the mouse thymocyte proliferation assay (section: 2.2.2.3). Mouse 
thymocytes were obtained from C57BL/6N mice and cultured at IXIO? cells/ml with 
three dilutions of supernatants (1:40，1:80 and 1:160) in the presence of 1 /xg/ml of 
Con A. 
2.2.2.6 Plaque forming cells (PFC) 
The method from Simpson and Gozzo (1978) was followed with some 
modifications. BALB/c An male mice in groups of four were intragastrically 
administered with two different concentrations of Mimosa extract (5.0 or 10.0 
g/kg/day; DWE = 26.5 or 53.0 g/kg/day) in saline continuously for 10 days. The 
control group was given the saline. On the sixth day, the mice were immunized by 
intraperitoneal injection of 2% SRBC in saline at 0.5 ml/mouse. After drug 
administration for 10 days, the mice were sacrificed by cervical dislocation. Their 
spleens were removed and teased through a sieve in PBS. The splenocytes were 
washed 2 times with PBS by centrifuging at 1,500 rpm for 5 minutes. The cell pellet 
was resuspended in PBS and adjusted to 5X10^ cells/ml. In each 75 mm X 10 mm 
culture tube, 1 ml of the splenocyte suspension was incubated with 1 ml of a 0.2% 
SRBC suspension in PBS and 1 ml of a 1:20 dilution of guinea pig complement. At 
the same time, a blank was prepared by 1 ml of PBS instead of splenocytes used in 
41 
the mixture. The mixtures were incubated at 37。C for 1 hour. Then they were 
centrifuged at 3,000 rpm for 5 minutes and the supernatant haemolysis was 
determined at O.D. 413 nm. Usually, each sample was done in quadruplication. 
2.2.2.7 Restoration on splenocyte blastogenesis of old mice 
BALB/c An male mice (20-week-old) in groups of four were administered 
with Mimosa extract by intragastrical administration at the dose level of 5.0 g/kg/day 
(DWE = 26.5 g/kg/day). Two control groups, group 1 (6-week-old) and group 2 
(20-week-old), were given the same volume of distilled water. After feeding for 10 
days, all mice were sacrificed and their splenocyte suspensions were prepared for the 
proliferation assay. The assay procedure was the same as that of the splenocyte 
proliferation (section: 2.2.2.2). The weights of their lymphoid organs, namely the 
spleen and thymus, were measured. 
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2.2.3 Assays for the toxicity of Mimosa pudica 
2.2.3.1 LD50 
ICR male or female mice were randomly divided in groups of fifteen. After 
fasting for 4 hours, each animal was given a single dose of different concentrations 
of the Mimosa extract by either intragastrical or intraperitoneal administration. The 
mice in the control group were given the vehicle. The animals were observed for 
general symptoms of toxicity and mortality for one week (Chan and Hayes, 1989). 
2.2.3.2 Enzyme assays 
Male or female Sprague-Dawley rats (200±20g) were randomly allotted to 
different test and control groups. After overnight fasting, the test groups were 
intraperitoneally injected with different dosages of Mimosa extract. The control 
group was injected with saline. After 10 hours, the rats were sacrificed. Their blood 
was collected by heart puncture and the serum was isolated for analyzing the enzyme 
levels of lactate dehydrogenase (LDH), creatine kinase (CK), glutamic oxalacetic 
transaminase (GOT) and glutamic pyruvic transaminase (GPT). Procedures for the 
enzyme assays were referred to appendix I-V. 
2.2.3.3 Subacute toxicity 
The method was modified from Mosberg and Hayes (1989) and Qureshi et al 
(1992). ICR female mice (15±lg) were randomly assigned into different test and 
control groups. Each group contained ten mice. The mice in the experimental 
groups were intragastrically given Mimosa extract at 2.5, 5.0, or 10.0 g/kg/day 
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(DWE = 13.3，26.5 or 53.0 g/kg/day). The mice in the control group was given the 
vehicle. The treatment was continued for 1 month. Animals were observed for 
external general symptoms of toxicity, change of body weight and mortality. After 
the completion of the drug administration, the animals were sacrificed. Their blood 
was collected for red blood cell (RBC) and total white blood cell (WBC) count and 
their serum was isolated for the enzyme assays: LDH, CK, GOT, GPT and ALP. 
The animals were subjected to a gross pathology examination and their vital organ 
weights were recorded. 
2.2.3.4 Reproductive toxicity 
The method from Kong et al. (1989) was followed. Female Sprague-Dawley 
rats (220±10g) were supplied by the Animal House, CUHK in the first morning 
when the presence of postcoital plug was observed. It was designated as Day-1 of 
pregnancy (PDj). They were randomly assigned into two groups with ten rats per 
group. The rats in the experimental group were orally administered with the Mimosa 
extract by stomach tube. The extract was dissolved in distilled water and was given 
daily for 10 days at the highest possible dose of 3.75 g/rat/day (DWE = 19.9 
g/rat/day) from PDi to PDjo- The rats in the control group were given the vehicle. 
The animals were autopsied at PDjg and the numbers of pregnant animals, 
implantation sites, normal fetuses and corpora lutea of pregnancy were recorded. 
2.2.4 Statistical analysis 
All results were expressed as the arithmetic mean 士 standard error. .Student's 




3.1 Assays for the Immunomodulatory Effects of Mimosa pudica 
3.1.1 In vitro study on the lymphocyte proliferation 
3.1.1.1 Splenocyte proliferation 
Splenocytes from C57BL/6N mice were used to study the mitogenic effect of 
Mimosa extract on the proliferation of T cells and B cells. Splenocytes were cultured 
with different concentrations of Mimosa extract in the presence or absence of the B 
cell mitogen LPS or the T cell mitogen Con A at their sub-optimal concentrations (10 
jug/ml of LPS and 1 ixg/ml of Con A). From trypan blue exclusion test, the non-
cytotoxic concentrations of the extract was found to be 100 /xg/ml or below. Within 
this concentration, the extract enhanced the proliferation of the splenocytes in a dose-
dependent manner. At the optimal concentration 100 /ig/ml, the proliferation rate 
was five times of the control (Figure 3.1). However, when the concentration was 
greater than 100 ixg/ml, the proliferation rate decreased. 
When the splenocytes were cultured in the presence of the B cell mitogen 
LPS, the addition of the extract enhanced the cell proliferation at-, the low 
concentrations (1-25 /zg/ml), but the proliferation decreased when the concentration 
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was greater than 25 /xg/ml (Figure 3.2). However, when the splenocytes were 
cultured in the presence of the T cell mitogen Con A, the addition of the extract did 
not show any stimulatory effect at the non-cytotoxic concentrations (<100 /xg/ml) 
(Figure 3.3). These results suggested that low concentrations of Mimosa extract had 
a strong stimulatory effect on splenocyte proliferation and a significant co-mitogenic 
activities with LPS but not with Con A. 
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Figure 3.1: /n vitro concentration-response curve of Mimosa pudica on the splenocyte 
proliferation. 
C57BL/6N splenocytes were cultured with different concentrations of the 
water extract of Mimosa pudica for 48 hours. Pulse labelling with 0.5 
jLcCi/well of tritiated thymidine was performed for 6 hours. 
Data are expressed as mean 士 S.E. 
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Figure 3.2: In vitro concentration-response curve of Mimosa pudica on the splenocyte 
proliferation in the presence of 10 /xg/ml LPS. 
C57BL/6N splenocytes were cultured with different concentrations of the 
water extract of Mimosa pudica for 48 hours. Pulse labelling with 0.5 
)uCi/well of tritiated thymidine was performed for 6 hours. 
Data are expressed as mean 士 S.E. 
48 
70 — 
3 6 0 - • c o n t r o l ^ X O Mimosa e x t r a c t 
讓 5 。 丨 
^ \ 
二 4 0 一 \ 
.2 〇 \ 
^ 3〇一 
謹 2 0 - \ 〇 
^ 10 -
CO 
Q I I 1 I I I I I 1 
0 100 200 300 400 500 
F i n a l c o n c e n t r a t i o n of Mimosa e x t r a c t (yczg/ml) 
Figure 3.3: In vitro concentration-response curve of Mimosa pudica on the splenocyte 
proliferation in the presence of 1 /xg/ml Con A. 
C57BL/6N splenocytes were cultured with different concentrations of the 
water extract of Mimosa pudica for 48 hours. Pulse labelling with 0.5 
/iCi/well of tritiated thymidine was performed for 6 hours. 
Data are expressed as mean 士 S.E. 
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3.1.1.2 Thymocyte proliferation 
In contrast to splenocytes which contain a mixture of T and B cell populations, 
thymocytes contain only T cells at different stages of maturation. Thymocyte culture 
was used to study the effect of Mimosa extract on the proliferation of these different 
populations of T cells and their mitogenic response to Con A. It was found that non-
cytotoxic concentrations (<100 //g/ml) of the extract could only cause a mild 
stimulatory effect on the thymocyte proliferation. At the concentration of 100 /xg/ml, 
it caused only an increase of 40% when compared with the control (Figure 3.4). 
When the thymocytes were cultured in the presence of Con A at three different 
concentrations of 1.0，1.5 or 3.0 /zg/ml, the addition of Mimosa extract inhibited the 
mitogenic response of thymocytes to Con A at all three concentrations. The 
concentration of the extract at 12.5 �ug/ml indicated the greatest inhibitory rate; 
further increase of the concentration did not show any further suppression (Figure 
3.5). The results showed that Mimosa extract exhibited only a weak stimulatory 
effect on thymocyte proliferation, but, the extract caused a suppressive effect on the 
mitogenic response of thymocytes to Con A. 
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Figure 3.4: In vitro concentration-response curve of Mimosa pudica on the thymocyte 
proliferation. 
C57BL/6N thymocytes were cultured with different concentrations of the 
water extract of Mimosa pudica for 72 hours. Pulse labelling with 0.5 
/xCi/well of tritiated thymidine was performed for 8 hours. 
Data are expressed as mean 士 S.E. 
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Figure 3.5: In vitro concentration-response curve of Mimosa pudica on the thymocyte 
proliferation in the presence of Con A. 
C57BL/6N thymocytes were cultured with different concentrations of the 
water extract of Mimosa pudica for 72 hours. Pulse labelling with 0.5 
/xCi/well of tritiated thymidine was performed for 8 hours. 
Data are expressed as mean 士 S.E. 
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3.1.2 In vivo study on the lymphocyte proliferation 
BALB/c An mice in groups of four were administered with Mimosa extract 
by intragastrical administration at one of the three different dose levels, 2.5, 5.0 or 
10.0 g/kg/day (DWE = 13.3，26.5 or 53.0 g/kg/day), for 10 days. The control 
group was given equal volume of saline. Splenocytes and thymocytes from these 
groups were then assayed for their mitogenic-induced lymphocyte proliferation. 
Table 3.1 showed that splenocytes from the groups fed with Mimosa extract had a 
higher proliferation rate than the control group. The greatest stimulatory effect was 
found at the dose of 5.0 g/kg/day at which the proliferation rate was four times 
greater than that in the control group. The stimulatory effect was also observed in 
the mitogenic response of splenocytes to LPS and Con A. It caused an increase of 
50-60% at the dose of 5.0 g/kg/day in the proliferation induced by either LPS or Con 
A. However, the mitogenic response to Con A was not in a dose-dependent manner 
as all three groups administered with the corresponding doses of Mimosa extract 
showed nearly the same degree of stimulation. 
However, thymocytes from the mice given the same dosages of Mimosa 
extract as those for the splenocyte assays did not show any enhancement in the cell 
proliferation when compared with the control group. Instead of stimulation, all three 
dose levels of the extract induced a reduction on the thymocyte proliferation by nearly 
50% (Table 3.2). Nevertheless, the suppression of the thymocytes could be reversed 
when mitogen Con A was added in the cell culture. At the dose of 5.0 g/kg/day, the 
thymocytes exhibited 85% enhancement in response to 2 figlmX of Con A. 
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Spleen and thymus weights were measured and the results did not show any 
significant change on the spleen weight after the administration of Mimosa extract. 
However, the treated-mice showed a slight decrease on thymus weight. There were 
decreases of 20% or 30% after the mice were fed with 5.0 or 10.0 g/kg/day of the 
extract, respectively (Table 3.3). 
54 
Table 3.1: In vivo effect of Mimosa pudica on the mice splenocyte proliferation. 
Treatment RPMI LPS(10 辟 /ml) Con A(1 ixg/ml) 
saline 503.17 40939.83 121150.00 
士 32.33 ±1080.56 土5673.900 
Mimosa extract 
2.5 g/kg/day 1514.50* 58706.25* 188351.67* 
±95.97 ±2829.81 士 3998.38 
5.0 g/kg/day 2652.00* 61041.25* 187151.67* 
±185.85 ±2593.88 士4650.86 
10.0 g/kg/day 1214.88* 51904.50* 183396.67* 
±99.53 ±1275.10 ±4572.26 
BALB/c An mice in groups of four were administered with either saline (control 
group) or one of the three dose levels of the water extract of Mimosa pudica (2.5, 5.0 
or 10.0 g/kg/day; DWE = 13.3，26.5 or 53.0 g/kg/day) by intragastrical 
administration for 10 days. Splenocytes were assayed for mitogenic response in vitro. 
Data are expressed as mean 士 S.E. 
* Significantly different when compared with the saline control group, PCO.Ol. 
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Table 3.2: In vivo effect of Mimosa pudica on the mice thymocyte proliferation. 
Treatment RPMI Con A(1 ；xg/ml) Con A (2 /xg/ml) 
saline 136.13 9708.04 57042.00 
±12.18 士751.66 ±3891.93 
Mimosa extract 
2.5 g/kg/day 69.75* 10384.50 95870.83* 
±4.56 ±826.06 ±5898.70 
5.0 g/kg/day 64.50* 14897.99* 105529.17* 
土 3.59 ±503.58 土 6441.21 
10.0 g/kg/day 77.50* 5896.91* 80244.44* 
±2.81 土 328.04 士 6025.38 
BALB/c An mice in groups of four were administered with either saline (control 
group) or one of the three dose levels of the water extract of Mimosa pudica (2.5，5.0 
or 10.0 g/kg/day; DWE = 13.3, 26.5 or 53.0 g/kg/day) by intragastrical 
administration for 10 days. Thymocytes were assayed for mitogenic response in 
vitro. 
Data are expressed as mean 士 S.E. 
* Significantly different when compared with the saline control group, P<0.01. 
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Table 3.3: In vivo effect of Mimosa pudica on the lymphoid organ weights. 
Organ weight (g) per lOOg body weight 
Treatment Body weight (g) 
spleen thymus 
saline 24.17 0.45 0.29 
±0.51 ±0.03 ±0.01 
Mimosa extract 
2.5 g/kg/day 23.65 0.42 0.30 
±0.31 ±0.01 ±0.02 
5.0 g/kg/day 23.40 0.41 0.23* 
±0.97 土 0.03 土 0.02 
10.0 g/kg/day 23.04 0.42 0.21* 
±0.59 土 0.01 ±0.02 
BALB/c An mice in groups of four were administered with either saline (control 
group) or one of the three dose levels of the water extract of Mimosa pudica (2.5, 5.0 
or 10.0 g/kg/day; DWE = 13.3, 26.5 or 53.0 g/kg/day) by intragastrical 
administration for 10 days. 
Data are expressed as mean ± S.E. 
* Significantly different when compared with the saline control group, P<0.05. 
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3.1.3 Phagocytic activity of macrophages 
In vitro study: 
Mouse peritoneal macrophages were incubated with different non-cytotoxic 
concentrations (confirmed by trypan blue exclusion test) of Mimosa extract (1-1000 
/Ag/ml). After incubation for 24 hours, neutral red which acted as a foreign particle 
was added to check i f the phagocytic activities of extract-treated macrophages were 
enhanced. The uptake of neutral red was measured at O.D. 540 nm and the actual 
amount was read from a standard curve (Appendix, Figure Al ) . Figure 3.6 showed 
that Mimosa extract enhanced the uptake of neutral red and the effect was in a dose-
dependent manner. At the optimal dose of 800 /xg/ml, the uptake was three times that 
of the control. Besides, the stimulatory effect of the extract was also observed in the 
presence of hydrocortisone and was also in a dose-dependent manner (Figure 3.7). 
The suppressive effects caused by hydrocortisone at lO'^M and lO'^M were reversed 
by Mimosa extract at the dose levels of 200 /xg/ml and 400 /xg/ml, respectively. 
In vivo study: 
BALB/c An mice in groups of four were administered with Mimosa extract 
by intragastrical administration at one of the three different dose levels of 2.5, 5.0 or 
10.0 g/kg/day (DWE 二 13.3，26.5 or 53.0 g/kg/day) for 10 days. The control group 
was given the same volume of saline. Peritoneal macrophages were obtained to study 
whether the treated-macrophages had any change on their phagocytosis activities. It 
was found that the macrophages did not show any change in the uptake of neutral red 
in all the three groups administered with different dosages of the extract when 
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compared with the control group (Figure 3.8). The same negative result was also 
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Figure 3.6: In vitro effect of Mimosa pudica on the phagocytosis of macrophages. 
C57BL/6N macrophages were cultured with different concentrations of the 
water extract of Mimosa pudica for 24 hours. 0.1% neutral red was added 
and incubated for another 30 minutes. The amount of uptake was measured 
at O.D. 540 nm. 
Data are expressed as mean 士 S.E. 
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Figure 3.7: In vitro effect of Mimosa pudica on the phagocytosis of macrophages in 
the presence of hydrocortisone. 
C57BL/6N macrophages were cultured with different concentrations of the 
water extract of Mimosa pudica for 24 hours in the presence of hydrocortisone 
(HC). 0.1% neutral red was added and incubated for another 30 minutes. 
The amount of uptake was measured at O.D. 540 nm. 
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Figure 3.8: In vivo effect of Mimosa pudica on the phagocytosis of macrophages. 
BALB/c An mice in groups of four were administered with either saline 
(control group) or one of the three different dose levels of the water extract 
of Mimosa pudica (2.5, 5.0 or 10.0 g/kg/day; D W E 二 13.3，26.5 or 53.0 
g/kg/day) by intragastrical administration for 10 days. Macrophages were 
cultured at 37。C for 24 hours. 0.1% neutral red was added and incubated for 
another 30 minutes. The amount of uptake was measured at O.D. 540 nm. 
Data are expressed as mean 士 S.E. 
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Figure 3.9: In vivo effect of Mimosa pudica on the phagocytosis of macrophages. 
BALB/c An mice in groups of four were administered with either saline 
(control group) or one of the three different dose levels of the water extract 
of Mimosa pudica (2.5, 5.0 or 10.0 g/kg/day; DWE = 13.3，26.5 or 53.0 
g/kg/day) by intragastrical administration for 10 days. Macrophages were 
cultured with different concentrations of hydrocortisone (HC) at 37°C for 24 
hours. 0.1% neutral red was added and incubated for another 30 minutes. 
The amount of uptake was measured at O.D. 540 nm. 
Data are expressed as mean 士 S.E. 
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3.1.4 Release of IL-1 by macrophages 
The effect of Mimosa extract on the synthesis of IL-1 was examined by 
culturing macrophages with different concentrations of the extract in the absence or 
presence of LPS. The quantity of IL-1 released was then assayed by Con A-
stimulated thymocyte proliferation. As the supernatant from macrophage culture 
contained some other factors such as thymine and prostaglandins besides IL-1, high 
concentration of the supernatant was found to inhibit thymocyte proliferation. 
However, the inhibitory effect of these factors could be eliminated when the 
supernatant was diluted by at least 40-fold (Otterness et al, 1988; Shang et al., 
1986). Therefore, three dilutions of the supernatant at 1:40，1:80 and 1:160 were 
made. The results showed that IL-1 released was suppressed by the extract when the 
concentration was 50 /xg/ml or greater (Figure 3.10). However, for LPS-stimulated 
macrophages the extract could enhance IL-1 released at the low concentrations up to 
200 jLtg/ml (Figure 3.11). At the concentration of 100 /xg/ml, the amount of IL-1 
released was 60% higher than that of the corresponding LPS control group when the 
supernatant was diluted at 1:40. 
64 
4 0 0 0 "1 
I I 1:40 ； [Z3 1:80 ; • 1:160 
3 5 0 0 - * 
？ T 工 
a -r I I 
^ 3 0 0 0 - T f 工 ^ 
^ 2 5 0 0 - I - - 「 - * 
^ 々 氺 木 
I 2000 \ : * ^ I / ； / p * 
^ 1500 - I ； / / f * * 
丄 1 0 0 0 - g / 5 / : / * / / 
： i i — 丨 」 _ i J i — 
b l a n k RPMI 1 25 50 200 300 400 
Final c o n c e n t r a t i o n of Mimosa e x t r a c t (yUg/ml) 
Figure 3.10: In vitro effect of Mimosa pudica on the release of IL-1 from 
macrophages. 
C57BL/6N macrophages were cultured with different concentrations of 
Mimosa extract for 24 hours. Supernatants were collected and made into three 
dilutions (1:40, 1:80 and 1:160). The IL-1 activity was determined using the 
thymocyte proliferation assay. The blank was the thymocyte culture without 
any supernatant. 
The data are expressed as mean 士 S.E. 
* Significantly different when compared with the corresponding control group 
(RPMI), P < 0 . 0 5 . 
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Figure 3.11: In vitro effect of Mimosa pudica on the release of IL-1 from LPS-
stimulated macrophages. 
C57BL/6N macrophages were cultured with different concentrations of 
Mimosa extract in the presence of 10 /xg/ml LPS for 24 hours. Supernatants 
were collected and made into three dilutions (1:40，1:80 and 1:160). The IL-
1 activity was determined using the thymocyte proliferation assay. The blank 
was the thymocyte culture without any supernatant. 
The data are expressed as mean 土 S.E. 
* Significantly different when compared with the corresponding control group 
(RPMI), P < 0 . 0 5 . 
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3.1.5 Plaque forming cell (PFC) assay 
As Mimosa extract was found to have mitogenic effect on B cells, plaque 
forming cell (PFC) assay was carried out to investigate if the extract could also 
enhance the primary humoral immune response. BALB/c An mice in groups of four 
were intragastrically given Mimosa extract at the dose of either 5.0 or 10.0 g/kg/day 
(DWE = 26.5 or 53.0 g/kg/day) for 10 days. The control group was administered 
with the same volume of saline. Then the splenocytes were prepared for the PFC 
assay four days after SRBC antigen sensitization. The amount of SRBC lysed was 
measured at O.D. 413 nm. Figure 3.12 showed that the O.D. value of the two test 
groups were increased. At the dose group of 10 g/kg/day, the increase was three 
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Figure 3.12: Primary humoral antibody response to SRBC in mice treated with 
Mimosa pudica. 
BALB/c An mice in groups of four were administered with either saline 
(control group) or one of the two dose levels of the water extract of Mimosa 
pudica (5.0 or 10.0 g/kg/day; DWE = 26.5 or 53.0 g/kg/day) by 
intragastrical administration for 10 days. Splenocytes were incubated with 
SRBC in the presence of guinea pig complement for 1 hour. The amount of 
lysis of SRBC were determined at O.D. 413 nm. 
The data are expressed as mean 士 S.E. 
* Significantly different when compared with the corresponding control group 
(RPMI) , P<0 .05 . 
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3.1.6 Restoration on splenocyte blastogenesis of old mice 
BALB/c An mice 20-week-old, in groups of four, were given Mimosa extract 
by intragastrical administration at the dose level of 5.0 g/kg/day (DWE = 26.5 
g/kg/day) for 10 days. Two control groups, group 1 (6-week-old) and group 2 (20-
week-old), were administered with the same volume of distilled water. Splenocytes 
were then assayed for their blastogenic responses in the presence or absence of the 
mitogens LPS and Con A. Table 3.4 showed that the mitogenic response of the 
control group 2 (20-week-old) decreased to nearly one half of the control group 1 (6-
week-old). From the test group fed with Mimosa extract, it indicated that the extract 
could partially restore the blastogenic response of the test group. A similar reversed 
effect could be observed in the presence of mitogens LPS or Con A. The effect was 
much more prominent in the presence of Con A as the proliferation rate of the test 
group (20-week-old) was restored nearly to the same level of the group 1 (6-week-
old). 
However, Mimosa extract did not show any significant change on the spleen 
weight and the thymus weight of the 20-week-old mice (Table 3.5). Both groups with 
20-week-olcl mice indicated a decrease on these lymphoid organs when compared with 
the 6-week-old mice. 
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Table 3.4: In vivo effect of Mimosa pudica on splenocyte blastogenesis of old mice. 
Mice with RPMI LPS(10 爬 /ml) Con A(1 /xg/ml) 
treatment 
6-week-mice 300.25 5903.91 8657.96 
distilled water ±11.04 士 197.62 ±505.17 
20-week-mice 152.88* 2280.75* 5433.03* 
distilled water 士7.05 ±39.92 士243.03 
20-week-mice 205.63*# 3242.：38*# 7848.19# 
Mimosa extract ±10.08 ±40.11 土271.16 
Young (6-week-old) or old (20-week-old) BALB/c An mice in groups of four were 
administered with either distilled water (control group) or Mimosa extract at the dose 
of 5.0 g/kg/day (DWE = 26.5 g/kg/day) by intragastrical administration for 10 days. 
Splenocytes were assayed for mitogenic response in vitro. Data are expressed as 
mean 士 S.E. 
* Significantly different when compared with the young mice (6-week-old) distilled 
water control group, P<0.05. 
# Significantly different when compared with the old mice (20-week-old) distilled 
water control group, P<0.05. 
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Table 3.5: In vivo effect of Mimosa pudica on the lymphoid organ weights of old 
mice. 
Mice with Organ weight (g) per lOOg body weight 
treatment Body weight (g) 
spleen thymus 
6-week-old 24.83 0.47 0.22 
distilled water ±0.46 ±0.02 士0.02 
20-week-olci 29.47* 0.34* o.lO* 
distilled water ±0.52 ±0.01 士0.01 
20-week-old 30.40* 0.36* 0.13* 
Mimosa extract ±0.65 ±0.01 ±0.02 
Young (6-week-old) or old (20-week-old) BALB/c An mice in groups of four were 
administered with either distilled water (control group) or Mimosa extract at the dose 
of 5.0 g/kg/day (DWE = 26.5 g/kg/day) by intragastrical administration for 10 days. 
Data are expressed as mean 士 S.E. 
* Significantly different when compared with the young mice (6-week-old) distilled 
water control group, P<0.05. 
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3.2 Results for the Toxicity of Mimosa pudica 
3.2.1 LD50 
ICR male mice (20±2g) were randomly divided into two groups of ten 
animals each. One group of mice was given Mimosa extract by intragastrical 
administration at the limit dose of 15.0 g/kg of the powder extract (DWE = 79.5 
g/kg). The control group was given the same volume of saline. The results showed 
that no mortality was observed after one week and the animals did not show any 
abnormal behaviour. 
ICR male or female mice in groups of fifteen were administered with Mimosa 
extract by intraperitoneal injection at different dose levels of 1.0-6.0 g/kg (DWE = 
5.3-31.8 g/kg). The number of dead animals was recorded within one week. By 
using the statistical graphic method of Litchfield and Qilcoxon (1947), the LD50 with 
95% confidence limit of male and female mice were found to be 3.3土0.8 g/kg (DWE 
=17.5土4.2 g/kg) and 3.4±0.9 g/kg (DWE == 18.0土4.8 g/kg), respectively (Figure 
3.13). The death time of the mice after drug administration was recorded (Tables 
3.6-3.7). It indicated that over one-third of the dead mice died after 24 hours. 
Hindlimb paralysis was observed in nearly half of the mice before death. 
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Figure 3.13: Dose-lethal toxicity curve of Mimosa pudica on mice. 
ICR mice in groups of fifteen were injected a single dose of different dose 
levels of Mimosa extract (1.0-6.0 g/kg; DWE = 5.3-31.8 g/kg) by 
intraperitoneal injection. LD50 in male and female mice were found to 
3.3土0.8 and 3.4士0.9 g/kg, respectively. 
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Table 3.6: Death time of female mice after i.p. injection of Mimosa pudica. 
Treatment of Death time after drug administration (day) 
"^Mimosa extract 
(g/kg) 1 2 3 4 5 
1 0 0 0 0 0 
2 0 4 0 0 0 
3 3 2 1 0 0 
4 8 1 0 0 0 
5 9 1 0 0 0 
6 11 0 0 0 0 
ICR mice in groups of fifteen were injected a single dose of different dose levels of 
Mimosa extract by intraperitoneal injection. 
*DWE = 5.3g dry plant material per g of extract 
Table 3.7: Death time of male mice after i.p. injection of Mimosa pudica. 
Treatment of Death time after drug administration (day) 
"^Mimosa extract 
(g/kg) 1 2 3 4 ^ 
1 0 0 0 0 0 
2 1 1 2 0 0 
3 2 3 1 0 0 
4 4 0 2 1 1 
5 10 1 0 0 0 
6 12 0 0 0 0 
ICR mice in groups of fifteen were injected a single dose of different dose levels of 
Mimosa extract by intraperitoneal injection. 
*DWE = 5.3g dry plant material per g of extract 
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3.2.2 Enzyme assays 
Male or female Sprague-Dawley rats (200±20g) in groups of six were 
administered with one of the different dose levels of 0.5-3.0 g/kg (DWE = 2.7-15.9 
g/kg) of Mimosa extract by intraperitoneal injection. The control group was injected 
with the same volume of saline. After 10 hours, the rats were sacrificed and their 
serum was obtained for the determination of the enzyme activities of LDH，CK, GOT 
and GPT. Preliminary study on the time course using the dose level of 1.5 g/kg 
(DWE = 8.0 g/kg) was conducted. This dosage was used because animal death was 
observed when the dose was greater than 1.5 g/kg. The results on the time course 
study indicated that all four enzyme activities could reach an optimal level 10 hours 
after the drug administration. Some of the enzyme activities, such as GOT, CK and 
LDH, started to return to normal after 12 hours (Appendix, Figures A3-A6). Since 
the animals may start to recover or the released enzymes are gradually removed from 
the circulation, the serum level of the enzyme activities start to decrease. Thus, 10-
hour time period was chosen for studying the dose-response relationship of different 
enzyme activities. 
The results showed that all the four enzymes, LDH, CK, GOT and GPT 
(Figures 3.14-3.17)，exhibited a dose-dependent relationship when Mimosa extract 
was given to rats by intraperitoneal injection. CK and GOT had a significant increase 
at the dose level of 1.0 g/kg or greater, while LDH had a significant elevation even 
at the lower dose level of 0.5 g/kg. However, an elevation of GPT could only be 
observed when the dose level of 2.5 g/kg was reached. Besides, some of the rats also 
showed a hindlimb paralysis when the dosage greater than 2.0 g/kg was given. 
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Figure 3.14: Dose-response curve of Mimosa pudica (i.p.) on the serum level of 
lactate dehydrogenase (LDH) of rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract by intraperitoneal injection. After 10 hours, serum was collected for 
the enzyme measurement. Data are expressed as mean 士 S.E. 
DWE = 5.3g dry plant material per g of extract 
* Significantly different when compared with the corresponding control group 
(RPMI) , P<0.05 . 
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Figure 3.15: Dose-response curve of Mimosa pudica (i.p.) on the serum level of 
creatine kinase (CK) of rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract by intraperitoneal injection. After 10 hours, serum was collected for 
the enzyme measurement. Data are expressed as mean 土 S.E. 
DWE = 5.3g dry plant material per g of extract 
* Significantly different when compared with the corresponding control group 
(RPMI) , P<0.05. 
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Figure 3.16: Dose-response curve of Mimosa pudica (i.p.) on the serum level of 
glutamic oxalacetic transaminase (GOT) of rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract by intraperitoneal injection. After 10 hours, serum was collected for 
the enzyme measurement. Data are expressed as mean 土 S.E. 
DWE = 5.3g dry plant material per g of extract 
* Significantly different when compared with the corresponding control group 
(RPMI) , P<0.05 . 
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Figure 3.17: Dose-response curve of Mimosa pudica (i.p.) on the serum level of 
glutamic pyruvic transaminase (GPT) of rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract by intraperitoneal injection. After 10 hours, serum was collected for 
the enzyme measurement. Data are expressed as mean 土 S.E. 
DWE = 5.3g dry plant material per g of extract 
* Significantly different when compared with the corresponding control group 
(RPMI) , P<0.05 . 
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3.2.3 Subacute toxicity test 
ICR female mice (15 土 Ig) in groups of ten were administered with Mimosa 
extract at one of the three different dose levels, 2.5, 5.0 and 10.0 g/kg/day (DWE = 
13.3，26.5 and 53.0 g/kg/day) for 30 days, by intragastrical administration. The 
control group was given the same volume of saline. From the physical observation, 
there was no behavioral change in all three test groups; the food and water intake 
were normal when compared with the control group. The growth rate was also 
normal (Figure 3.18). After one month, the mice were sacrificed and their serum 
was collected for biochemical tests. Five enzyme assays, LDH, CK, GOT, GPT and 
ALP, were measured, but none was affected. Haematological studies included red 
blood cell (RBC) count and total white blood cell (WBC) count. It was found that 
all five enzymes did not increase in serum level when compared with those in the 
control (Table 3.8). The RBC count and total WBC count did not show any 
significant change (Table 3.9). All the animals were subjected to a gross pathological 
examination and the result did not show any abnormality. Among the vital organ 
weights recorded (Table 3.10)，only the weight of liver showed a significant decrease 
in the dose groups of 2.5 and 5.0 g/kg/day, but no increase in the liver enzymes 
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Figure 3.18: Effect of Mimosa pudica (p.o.) on the body weight of mice after 
subacute treatment. 
ICR mice in groups of ten were orally given with either saline (control group) 
or one of the three different dose levels of Mimosa extract (2.5, 5.0 or 10.0 
g/kg/day; DWE = 13.3, 26.5 or 53.0 g/kg/day) for one month. Data are 






















































































































































































































































































































































































































































Table 3.9: Effect of subacute oral administration of Mimosa pudica on the blood cell 
counts of mice. 
Treatment RBC counts (XlOVml) Total WBC counts (XlOVml) 
s业ne 817.13 士 60.85 112.50 土 30.06 
Mimosa extract 
2.5 g/kg/day 753.14 土 44.04 96.44 土 31.50 
5.0 g/kg/day 723.14 土 56.35 105.38 士 39.50 
10.0 g/kg/day 869.75 土 50.02 101.56 ±11.13 
ICR mice in groups of ten were orally given with either saline (control group) or one 
of the three different dose levels of Mimosa extract (2.5, 5.0 or 10.0 g/kg/day; DWE 
=13.3 , 26.5 or 53.0 g/kg/day) for one month. Data are expressed as mean 土 S.E. 



























































































































































































































































































































































































































































































































3.2.4 Reproductive toxicity 
Female Sprague-Dawley rats (220土 lOg) after successful coitus were subjected 
to drug administration. They were divided into two groups with ten animals each. 
One group was given Mimosa extract at the highest possible daily dose of 3.75 
g/rat/day (DWE = 19.9 g/rat/day) from PD, to PD,o by intragastrical administration. 
The control group was given the same volume of distilled water. The results were 
shown in Tables 3.11-3.14. It was found that Mimosa extract did not affect the 
percentage of pregnancy. It also did not show any reduction on the number of 
implantation sites, the number of normal fetuses and the number of corpora lutea per 
pregnant animal when compared with the control. 
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Table 3.11: Effect of Mimosa pudica (p.o.) on the percentage of pregnancy in rats. 
Treatment No. of animal pregnant Percentage of pregnancy 
per no. of animal dosed 
distilled water 10/10 100 
Mimosa extract 10/10 100 
Sprague-Dawley rats in groups of ten were orally administered with either distilled 
water (control) or Mimosa extract at the dose of 3.75 g/rat/day (DWE = 19.9 
g/rat/day) from PD^ to PDjo- Rats were autopsied at PDi6. 
Table 3.12: Effect of Mimosa pudica (p.o.) on the fetus implantation in rats. 
Treatment No. of implantation sites Percentage of reduction 
per pregnant animal 
distilled water 14 • 5 土 1.9 --
Mimosa extract 14.6 土 1.5 0 
Sprague-Dawley rats in groups of ten were orally administered with either distilled 
water (control) or Mimosa extract at the dose of 3.75 g/rat/day (DWE = 19.9 
g/rat/day) from PDi to PDio- Rats were autopsied at PDi^. Data are expressed as 
mean 士 S.E. 
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Table 3.13: Effect of Mimosa pudica (p.o.) on the fetus formation in rats. 
Treatment No. of normal fetuses Percentage of normal 
per pregnant animal 
distilled water 12.7土2.75 -
Mimosa extract 13.7±2.63 107.9 
Sprague-Dawley rats in groups of ten were orally administered with either distilled 
water (control) or Mimosa extract at the dose of 3.75 g/rat/day (DWE = 19.9 
g/rat/day) from PD! to PD,o. Rats were autopsied at PDig. Data are expressed as 
mean 士 S.E. 
Table 3.14: Effect of Mimosa pudica (p.o.) on corpora lutea formation in rats. 
Treatment No. of corpora lutea Percentage of reduction 
per pregnant animal 
distilled water 14.7土 1.8 --
Mimosa extract 15.1 ± 1.0 0 
Sprague-Dawley rats in groups of ten were orally administered with either distilled 
water (control) or Mimosa extract at the dose of 3.75 g/rat/day (DWE = 19.9 
g/rat/day) from PDj to PDjo. Rats were autopsied at PDi^. Data are expressed as 
mean 土 S.E. 
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Chapter Four 
General Discussion on the Immunomodulatory Effects 
and Toxicity of Mimosa pudica 
4.1 Immunomodulatory Effects of Mimosa pudica 
a) Effect of Mimosa pudica on lymphocyte proliferation 
Splenocytes contain a mixed population of B and T lymphocytes while 
thymocytes contain different sub-populations of T cells. By using different mitogens 
for B cells and T cells, the effect of a drug or chemical on these two cell types can 
be studied. Moreover, by comparing the mitogenic response of T cells of splenocytes 
and of thymocytes to Con A, the collaboration of T cells and B cells can be 
determined (Andersson et al., 1972). 
In in vitro assays, the non-cytotoxic concentrations (1-100 jLtg/ml) of Mimosa 
extract showed a strong stimulatory effect on splenocyte proliferation (Figure 3.1). 
This stimulatory effect was also be observed when the splenocytes cultured in the 
presence of LPS (Figure 3.2)，but not in the presence of Con A (Figure 3.3). 
However, the non-cytotoxic concentrations of the extract did not enhance thymocyte 
proliferation (Figure 3.4). Moreover, it inhibited the mitogenic response of the 
thymocytes to Con A (Figure 3.5). As splenocytes contained a mixture of B and T 
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lymphocytes while thymocytes contained only T lymphocytes, the mitogenic effect of 
Mi麵“ extract might only act on B cells but not on T cells. Since the activation of 
B cells can be stimulated either by T-dependent antigens which require the 
collaboration of T-helper cells or by T-independent antigens which stimulate the 
proliferation and differentiation of B cells directly (Lanier, 1991; Kumazawa et al., 
1982)，there is a possibility that Mimosa extract contains some components which act 
as antigens for B cell activation. 
By the use of trypan blue exclusion test (Hudson and Hay, 1976), it was found 
that the concentration of Mimosa extract greater than 100 jxglml had a slight cytotoxic 
effect to the lymphocytes. Therefore, the decrease of the splenocyte proliferation in 
the presence or absence of LPS or Con A at the concentrations of Mimosa extract 
greater than 100 /xg/ml might be due to cytotoxicity (Figures 3.1-3.3). However, the 
inhibition on mitogenic response of thymocytes to Con A was not due to the cytotoxic 
effect since the concentration used was within the non-cytotoxic dose range (Figure 
3.5). From the in vitro study, it may be proposed that components in Mimosa extract 
activate B cells but suppress T cells. 
The in vivo study was consistent with the in vitro study that Mimosa extract 
could enhance splenocyte proliferation and its mitogenic response to LPS (Table 3.1). 
Instead of suppression, the in vivo study found that the extract could also strengthen 
the mitogenic response of splenocytes and thymocytes to Con A (Tables 3.1-3.2). 
However, it showed an inhibition on thymocyte proliferation in the absence of the 
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mitogen. As immune response is the outcome of collaboration of different cell 
populations, results observed in the in vivo system could be different from the isolated 
/n vitro system. The degree of lymphocyte activation is also a function of cellular 
regulation for the outcome of immune response. T cells are heterogenous in nature 
and comprised of different sub-populations. Therefore, there is the possibility that 
Mimosa extract might have greater effect on certain sub-population of T cells such 
as suppressor T cells. 
b) Effect of Mimosa pudica on phagocytosis of macrophages 
The engulfing and killing of infectious agents by macrophages represent a 
major host defense mechanism. Therefore, strengthening the phagocytic capability 
of macrophages can reduce the susceptibility to infection. From the in vitro study 
(Figures 3.6-3.7), it was noted that Mimosa extract could strongly enhance the 
phagocytic activities of peritoneal macrophages. The same stimulatory effect was also 
observed even in the presence of hydrocortisone. Hydrocortisone is a kind of 
glucocorticoids which are potent immunosuppressive agents. They have multiple 
effects on many stages in inflammatory and immune processes. The major cell 
targets are mononuclear leukocytes, particular lymphocytes and cells of the 
monocyte/macrophage lineage (Fauci, 1978; Goulding and Guyre, 1993). Werb et 
al (1978) suggested that some of these effects were mediated through direct 
interaction of glucocorticoids with macrophages by specific receptor binding on 
macrophages. Grasso et al (1982) found that these agents might contribute to the 
decrease in host resistance by directly inhibiting the phagocytic capability of 
90 
macrophages. As our findings indicated that Mimosa extract could restore the 
suppressive effect on the phagocytic capability of macrophages caused by 
hydrocortisone, it might be suggested that the extract could strengthen the. host 
defense system. 
On the other hand, the in vivo studies indicated that Mimosa extract did not 
show any effect on the phagocytic capability of macrophages in both the absence or 
presence of hydrocortisone in the culture (Figures 3.8-3.9). Similar to the findings 
of hydrocortisone, Wiener et al (1972) found that in vitro hydrocortisone decreased 
phagocytosis in mouse peritoneal macrophages, but Van Zwet et al (1975) found that 
in vivo hydrocortisone produced no effect on the phagocytosis in mouse peritoneal 
macrophages. Although the reasons for the inconsistent results of some in vitro and 
in vivo studies are unknown, some hypotheses have been made that the stimulatory 
effects of some drugs are reversible or not persistent so that the macrophages of the 
in vivo study do not show any enhancement in phagocytosis once the administration 
of the drug is stopped (Grasso et al,, 1982). Therefore, the different responses of 
macrophages in the in vitro and in vivo studies to Mimosa extract might be explained 
. t o have different mechanisms and further studies are required. 
c) Effect of Mimosa pudica on IL-1 release by macrophages 
Macrophages release many cytokines to regulate the immune response. IL-1 
is one of the major cytokines responsible for the immunoregulation. It can stimulate 
the proliferation and differentiation of T and B cells and potentiate their responses to 
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other lymphokines. It also activates natural killer cells and macrophages, either 
directly or indirectly, via other lymphokines (Feldmann and Male, 1989). As IL-1 
is a stimulator responsible for T cell activation, the suppression on the release of IL-1 
caused by Mimosa extract (Figure 3.10) agreed with the results of the thymocyte 
proliferation studies (Figure 3.5). A possibility might be suggested that the inhibitory 
effect of Mimosa extract on thymocyte proliferation could be caused either by 
suppressing the proliferation of T cells directly or by inhibiting the release of IL-1 
by macrophages or by both mechanisms. Since the concentration of the extract was 
within the non-cytotoxic dose range, the decrease in the IL-1 released was probably 
due to the inhibitory effect of the extract but not a cytotoxic effect. 
However, there was an opposite effect of the extract on the IL-1 released by 
the LPS-stimulated macrophages (Figure 3.11). Low concentrations of the extract 
could slightly enhance the release of IL-1. This synergistic effect with LPS to induce 
the IL-1 release agreed with the results in splenocyte proliferation. As IL-1 can 
activate B cells, there might be the possibility that the B cell activation induced by 
the extract was via both the direct interaction of the extract components on B cells 
and indirectly by the co-stimulating effect of IL-1. It is known that LPS mainly 
stimulates the level of intracellular IL-1, the amount of IL-1 released by macrophages 
is low. Since this assay can only determine the extracellular IL-1, the level of 
intracellular IL-1 cannot be measured (Gery et al。1981; Shang et al., 1986). 
Therefore, it is not clear whether Mimosa extract can also increase the intracellular 
IL-1 or not. This can be further investigated by using the other reagents such as 
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silica or glucocerebroside which can act synergistically with LPS on macrophages to 
increase the release of intracellular IL-1 (Gery et al., 1981). 
d) Effect of Mimosa pudica on primary humoral iiiinuiiic response 
After activation, B lymphocytes will proliferate and differentiate into plasma 
cells to secrete antibodies. The direct plaque forming assay can reflect the 
productivity of antigen-specific IgM which are capable of causing the coniplement-
mediated lysis of the T-dependent antigen SRBC (Simpson and Gozzo, 1978; Steward 
and Male, 1989). This assay is used to study the later stage of the B cell response 
to an antigen, the enhancement of the lysis of SRBC may be clue to the increase of 
the number of plaque forming cell and/or the increase of the release of IgM per cell 
(Yang and Zhang, 1990). Thus, it was suggested that the enhancement of the lysis 
of SRBC observed in our results (Figure 3.12) might be due to one or both of these 
mechanisms and further studies are needed. 
e) Effect of Mimosa pudica on the restoration of splenocyte blastogenesis of 
old mice 
According to the studies on the lymphocytes and macrophages, the results 
showed that Mimosa extract had immunostimulatory effect. It was therefore 
interesting to see whether the extract could restore the impaired immunity as there 
was clinical study showing M. pudica could cure chronic bronchitis of the aged 
people (Anonymous, 1972). Lymphocyte proliferation of the old mice was used as 
the assay model in this preliminary study. From the previous studies on the 
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lymphocyte proliferation, the extract at the dose of 5.0 g/kg/day (DWE = 26.5 
g/kg/day) exhibited the greatest enhancement effect. Therefore, this dose level was 
chosen in this restoration study. The results indicated that the extract could partially 
restore the blastogenic response of the lymphocytes, especially on the mitogenic 
response to the T cell mitogen Con A (Table 3.4). Although the extract could 
enhance the blastogenesis of the lymphocytes, the lymphoid organs spleen and thymus 
did not show any significant change (Table 3.5); this might be due to the short dosing 
period. As the aging process is very complicated and involves multiple factors, more 
extensive studies should be performed to investigate i f Mimosa pudica can be used 
to treat immunodeficiency. 
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4.2 Toxicity of Mimosa pudica 
a) LD50 
Al l chemicals can produce toxicity at an unreasonably high dose. It is 
therefore misleading to demonstrate acute toxicity at such conditions which may be 
irrelevant to the test substances themselves (Chan and Hayes, 1989). In the present 
acute toxicity study, the test limit dose of 15.0 g/kg was administered orally to mice 
in a single dose and neither mortality nor abnormal behaviour was seen. This dose 
level is equivalent to 79.5g dry weight of the herb per kg body weight. Thus, it can 
be suggested that Mimosa extract is practically non-toxic or non-lethal after an acute 
oral exposure (Table 1.1). 
However, i f the extract was applied to the mice by intraperitoneal injection, 
mortality was observed when the dosages were at 2.0 g/kg (DWE = 10.6 g/kg) or 
greater (Figure 3.13). Among all the dead animals, nearly one third of the mice died 
after 24 hours. Death happened after the first 24 hours may be due to delayed toxic 
effects which can be direct or indirect (WHO, 1978). As the symptom of hindlimb 
paralysis was observed in nearly half of the dying mice, there is the possibility that 
intraperitoneal injection of the extract may exert its toxic effect on specific systems, 
such as muscular system, and eventually lead to death. 
b) Enzyme assays 
From the result of LD50, it was found that the toxicity for oral administration 
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of Mimosa extract was too low for carrying out the enzymatic assays. Therefore, 
enzyme activity changes were checked only for intraperitoneal injection of Mimosa 
extract. Although the enzymes that we used in this study are not organ-specific and 
widely distributed in the body tissues, we still can use them to narrow down the 
possible target organs by combining the pattern of the enzymatic assays and some 
intoxicated symptoms (Walmsley and White, 1988). The results of the enzymatic 
assays showed that all the four test enzymes, LDH, CK, GOT and GPT, were 
increased in serum level when the extract was injected at the sublethal dosages 
(Figures 3.14-3.17). Since liver, heart, skeletal muscle and kidney are the principal 
sources of LDH and GOT, the elevation of these two enzymes suggests that these 
organs may be involved in the Mimosa intoxication. Although GPT is also rich in 
heart, skeletal muscle and kidney, liver contains much greater concentration than the 
other organs. A significant increase of GPT could only be observed at a much higher 
dose level (2.5 g/kg) than that of the other enzyme activities, at which the dose level 
as low as 0.5-1.0 g/kg would be sufficient to cause a significant elevation of the 
enzyme activities, it may suggest that liver is not the primary target organ of Mimosa 
intoxication. Skeletal muscle is the major source of CK, the elevation of CK activity 
at the dose level of 1.0 g/kg suggests that skeletal muscle may be the primary target 
organ. This result was consistent with the findings that the symptom of hindlimb 
paralysis was observed in some rats of this study and also in mice during the study 
of LD50. Thus, further studies can be conducted by using some organ-specific 
isozymes such as carbonic anhydrase I I I ( V ^ n ^ e n et al, 1988) to verify that the 
skeletal muscle is involved in the Mimosa intoxication. Besides, a more direct 
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histological study of the vital organs can also be carried out in addition to enzyme 
assays. 
c) Subacute toxicity 
Overall speaking, from the results of physical, biochemical and pathological 
examinations in the subacute toxicity test, Mimosa extract did not show any 
significant toxic effect. Although there was a slight decrease on the weight of liver, 
the decrease could only be observed at the two dose groups of 2.5 and 5.0 g/kg/day 
(DWE = 13.3 and 26.5 g/kg/day) but not at the higher dose group of 10.0 g/kg/day 
(DWE = 53.0 g/kg/day) (Table 3.10). Moreover, LDH, ALP, GOT and GPT are 
present abundantly in liver, but the absence of significant increase in these enzyme 
activities might indicate that the liver was not intoxicated (Table 3.8). It is realized 
that normal biological variations will occasionally show up as statistically significant 
changes (Mosberg and Hayes, 1989). Therefore, the slight decrease of the liver 
weight might be probably due to the biological variation as a great variation could 
also be observed in the enzyme assays. 
Mimosa pudica is known to contain a toxic amino acid: mimosine (Notation 
and Spenser, 1964). Previous toxicity studies on mimosine demonstrated adverse 
biological effects when animals were fed with an animal diet containing 0.5-1.0% of 
mimosine (approximately equivalent to 0.8-1.6 g/kg) (Lin and Ling, 1961; Yang et 
al，1968; Von Sallmann and Grimes, 1959; Crounse et al.，1962; Hylin and Lichton， 
1965; Dewreede and Way man, 1970). In our preliminary study, mice intragastrically 
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fed with 0.5 g/kg/day of mimosine for 1 month, showed a growth retardation by 70-
80%. However, the Mimosa extract did not show any toxic effect when it was 
administered orally. Therefore, the mimosine content present in the Mimosa extract 
might be negligible or at least lower than the toxic dose used in this study. Further 
chemical analysis are required to determine the mimosine content in the extract 
quantitatively. 
d) Reproductive toxicity 
As the amount of Mimosa extract was administered at the highest possible dose 
of 3.75 g/rat/day (DWE = 19.9 g/rat/day) in the reproductivity test, no abnormal 
change on the number of fetus implantation, normal fetuses and corpora lutea could 
suggest that Mimosa extract did not cause any adverse effect on early pregnancy 
(Tables 3.11-3.14). However, whether longer exposure to the extract can cause 




From the results of the immunomodulatory studies on the water extract of 
Mimosa pudica, it can be concluded that Mimosa extract has a modulatory effect on 
both cellular and humoral immunities. 
In in vitro studies, Mimosa extract showed a significant stimulatory effect on 
splenocyte proliferation and a co-mitogenic effect with LPS but not with Con A. 
However, it did not show stimulation on thymocyte proliferation. Moreover, it 
inhibited the thymocyte proliferation in the presence of Con A. Therefore, there is 
the possibility that the extract exerts its stimulatory effect on B cells but suppressive 
effect on T cells. Further studies can be conducted to verify this stimulatory effect 
on B cells by depleting T cell populations in the splenocytes to obtain a B cell 
population culture. The method can be done by treating spleen cells with appropriate 
monoclonal antibody plus complement (Kumazawa et al., 1982). 
The immunomodulatory action of Mimosa extract is not only effective on the 
in vitro system but also on the in vivo system. The extract can enhance the 
splenocyte proliferation and its mitogenic response to both LPS and Con A. 
However, the extract inhibits the thymocyte proliferation in the absence of mitogens 
.but enhances thymocyte proliferation in the presence of Con A. As a conclusion for 
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the in vitro and in vivo splenocyte and thymocyte proliferation studies, it might be 
suggested that B cells and T cells were the target cells of Mimosa extract. However, 
it is unclear whether Mimosa extract exerts its effects directly on B and T cells or 
indirectly on some other accessory cells such as macrophages which are known to 
play an essential role in the induction of specific immune responses. As the different 
sub-populations of T cells, such as suppressor T cells and helper T cells, B cells and 
mononuclear cells are all capable of modifying the degree of proliferation response, 
the exact mechanism or the precise cellular targets for Mimosa extract have not yet 
been identified and some other experiments may be carried to verify these findings. 
Besides the modulatory effect on lymphocytes, in vitro administration of 
Mimosa extract can also enhance the phagocytosis of macrophages and reverse the 
inhibition caused by in vitro addition of hydrocortisone to the cell culture. Since 
phagocytosis is only one of the process of macrophages to protect the host from 
infection, the effect of Mimosa extract on the ability of degranulation, oxygen 
metabolism, and bactericidal activity of macrophages may also be carried out to 
ensure its effect on strengthening the host defense system against infection. 
Mimosa extract inhibits the release of IL-1 by macrophages but enhances the 
‘ release in the presence of LPS. Further experiments are required to work out the 
exact mechanism. As Mimosa extract can affect the release of cytokine IL-1 by 
macrophages, whether it can affect the release of tumour necrosis factor" (TNF) is 
worthy of studying. TNF is another important cytokine released by macrophages and 
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have many effects in common with IL-1; there is the possibility that the release of 
TNF may also be affected by Mimosa extract. I f the extract can induce the release 
of TNF, a series of studies can be carried out on its anti tumour activity. 
Besides the effect on the release of IL-1, Mimosa extract also enhances the 
primary humoral immune response by increasing the release of IgM from antibody-
forming-cells. Since IgM is only one of the five classes of immunoglobulins 
produced by plasma cells, other assays can be carried out to see i f the production of 
other classes of immunoglobulins is also induced by the extract. 
Generally, immunopotentiating agents can augment the immune responses or 
normalize a depressed response, they can be used to combat cancer, reverse 
iatrogenic immunosuppression, treat immunodeficiency and chronic infection (Goust 
et aL, 1990). In conclusion for the immunomodulatory effect of Mimosa extract, it 
shows some stimulatory effect on both the cellular and humoral immunities. 
Moreover, the study on the blastogenic response of the 20-week-old mice to Mimosa 
extract showed that the extract could partially restore the impaired immunity. 
Therefore, these results may partially support the traditional use of this herb in 
treating some inflammatory diseases or chronic infection. 
It would be relevant to note that immunomodulatory properties were also 
found in another species of Mimosa, namely M. tenuiflora. Villarreal et 'al (1991) 
reported that three different extracts of Mimosa tenuiflora had different patterns of 
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immune responses even on the same cell line. They found that the ethylacetate and 
butanol extracts inhibited cell growth, but the petroleum ether extract significantly 
enhanced proliferation in both human embryonic fibroblasts W138 and KB cells. 
There is a possibility that the aqueous extract of Mimosa pudica may also contain 
various components that exhibit diverse and sometimes opposite effects on cellular 
proliferation in in vivo and in vitro animal models. 
Besides the study on the immunomodulation, Mimosa pudica is also subjected 
to the toxicological studies in order to ensure the safe use of the herb. From the 
results of acute and subacute toxicity tests, it can be concluded that Mimosa extract 
is practically non-toxic when taken orally, causing no mortality, no change in body 
weight, no change in serum enzyme level and no gross anatomical change in vital 
organs. Moreover, the extract also cannot affect the early pregnancy when it is given 
orally. However, when the extract was injected intraperitoneally, mortality and toxic 
symptoms such as the increase in serum enzyme levels and hindlimb paralysis were 
observed. It is known that different route of drug administration can significantly 
affect the toxic effect of a compound by the differences on local effects; absorption 
and distribution; and metabolism (Gad and Chengelis, 1988). Thus, the toxicity of 
Mimosa extract is probably due to less the bioavailability as eliminated via passing 
through the gastro-intestinal tract or first pass effect. 
As a conclusion, the results of our present studies showed that Mimosa pudica 
had immunostimulatory effects. Although the potency was not high when the extract 
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was given orally, its stimulatory effects may play a role in some of the traditional 
uses of this herb. 
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Figure A l : Calibration curve showing O.D. value of the amount of neutral red. 
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Appendix I: Procedure on determining the activity of lactate dehydrogenase 
(LDH) 
1. Prepare the sample start reagent by mixing 10 ml reagent A, which consists of 
0.194 mmol/L NADH and 54 mmol/L phosphate buffer of pH 7.5，with 0.4 
ml reagent B which consists of 16.2 mmol/L pyruvate. 
2. Set the spectrophotometer wavelength at 340 nm, absorbance reading to zero with 
water as reference and temperature of the cuvet compartment to 25°C. 
3. Add 2.5 ml of the prewarmed sample start reagent and 0.1 ml of sample to the 
cuvet and mix immediately by inversion. 
4. Incubate for 30 seconds. 
5. Read and record absorbance at 340 nm versus water as reference and start a 
stopwatch at the same time. 
6. Continue incubation at 2 5 a n d record absorbance exactly 1，2 and 3 minutes, 
following initial absorbance reading. 
7. Determine the mean absorbance change per minute (i^^A/min) and calculate LDH 
activity by multiplying c^jA/min with the factor 4180. 
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Appendix II: Procedure on determining the activity of creatine kinase (CK) 
1. Prepare the sample start reagent by combining 10 ml reagent A, which consists 
of 2.28 mmol/L ADP, 5.7 mmol/L adenosine monophosphate, 2.28 mmol/L 
NADP, 22.8 mmol/L N-acetyl-L-cysteine, 2850 U/L HK (yeast), 1710 U/L 
G-6-PDH (Lm), 11.4 mmol/L magnesium ions, 22.8 mmol/L D-glucose, 11.4 
/zmol/L Di(adenosine 5,)pentaphosphate and 2.28 mmol/L EDTA, with 1 ml 
reagent B which consists of 342 mmol/L creatine phosphate and 1.14 mol/L 
imidazole buffer of pH 6.7. 
2. Set the spectrophotometer wavelength at 340 nm, absorbance reading to zero with 
water as reference and temperature of the cuvet compartment to 25°C. 
3. Add 2.5 ml of the prewarmed sample start reagent and 0.1 ml of sample to cuvet 
and mix immediately by inversion. 
4. Incubate for 3 minutes. 
5. Read and record absorbance at 340 nm versus water as reference and start a 
stopwatch at the same time. 
6. Continue incubation at 25°C and record absorbance exactly 1, 2 and 3 minutes, 
following initial absorbance reading. 
7. Determine the mean absorbance change per minute ((^A/min) and calculate CK 
activity by multiplying (^A/min with the factor 4180. 
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Appendix III: Procedure on determining the activity of aspartate 
aminotransferase / glutamic oxalacetic transaminase (AST/GOT) 
1. Add 0.5 ml substrate solution, which consists of 0.2 mol/L DL-aspartate and 1.8 
mmol/L a-ketoglutaric acid in phosphate buffer of pH 7.5, into a test tube and 
prewarm it in a 37°C water bath. 
2. Add 0.1 ml sample and mix it gently. 
3. Incubate for 1 hour at the water bath. 
4. Add 0.5 ml color reagent, which contains 20 mg/dL 2,4-dinitrophenylhydrazine 
(DNP) in IN hydrochloric acid, and shake gently to stop the reaction. Leave 
it at room temperature. 
5. After 20 minutes, add 5 ml 0.4N sodium hydroxide solution and mix by 
inversion. 
6. Wait at least 5 minutes. 
7. Read and record absorbance at wavelength 505 nm using water as reference. 
8. Determine GOT activity from the calibration curve (Figure A2). 
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Appendix IV: Procedure on determining the activity of alanine 
aminotransferase/glutamic pyruvic transaminase (ALT/GPT) 
1. Add 0.5 ml substrate solution, which consists of 0.2 mol/L DL-alanine and 1.8 
mmol/L Qf-ketoglutaric acid in phosphate buffer of pH 7.5, into a test tube and 
prewarm it in a 37°C water bath. 
2. Add 0.1 ml sample and mix it gently. 
3. Incubate for 30 minutes at the water bath. 
4. Add 0.5 ml color reagent, which contains 20 ing/dL 2,4-dinitrophenylhydrazine 
(DNP) in I N hydrochloric acid, and shake gently to stop the reaction. Leave 
it at room temperature. 
5. After 20 minutes, add 5 ml 0.4N sodium hydroxide solution and mix by 
inversion. 
6. Wait at least 5 minutes. 
7. Read and record absorbance at wavelength 505 nm using water as reference. 
8. Determine GPT activity from the calibration curve (Figure A2). 
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Procedure for preparing a calibration curve for the measurement of GOT or 
GPT activities 
1. Add different volumes of the solutions indicated in the following table into test 
tubes: 
tube *calibration substrate water serum GOT serum GPT 
no. standard solution (ml) activity activity 
solution (ml) (ml) (SF Units/ml) (SF Units/ml) 
1 0.0 0.5 0.1 0 0 
2 0.05 0.45 0.1 20 23 
3 0.1 0.4 0.1 55 50 
4 0.15 0.35 0.1 95 83 
5 0.2 0.3 0.1 148 125 
6 0.25 0.25 0.1 216 -
* Calibration standard solution consists of 1.5 mmol/L sodium pyruvate in phosphate 
buffer of pH 7.5. 
2. Add 0.5 ml color reagent to each tube. Shake gently and leave at room 
temperature. 
3. After 20 minutes, add 5 ml 0.4 N sodium hydroxide solution to each tube and mix 
by inversion. 
4. Wait at least 5 minutes. 
5. Read and record the absorbance at wavelength 505 nm using water as reference. 
6. Plot GOT and GPT calibration curves of absorbance values versus the 
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Figure A2: Calibration curves of glutamic oxalacetic transaminase (GOT) and 
glutamic pyruvic transaminase (GPT) activities. 
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Appendix V: Procedure on determining the activity of alkaline phosphatase 
(ALP) 
1. Prepare the sample start reagent by combining 25 ml reagent A, which consists 
of 0.607 mmol/L magnesium ions and 1.214 mol/L diethanolamine buffer of 
pH 9.8, with 5 ml reagent B which contains 60.8 mmol/L p-nitrophenyl 
phosphate. 
2. Set the spectrophotometer wavelength at 405 nm, temperature of cuvet 
compartment to 30°C and absorbance reading to zero with water as reference. 
3. Add 3 ml of the prewarmed sample start reagent and 0.05 ml of sample to the 
cuvet. Mix immediately by inversion. 
4. Read absorbance at 405 nm versus water as reference and start a stopwatch at the 
same time. 
5. Continue incubation at SC'C and record absorbances after exactly 1，2 and 3 
minutes, following the initial absorbance reading. 
6. Determine mean absorbance change per minute (t^A/min) and calculate ALP 
activity by multiplying t^A/min by factor 3306. 
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Figure A3: Serum level of lactate dehydrogenase (LDH) at different time after i.p. 
injection of Mimosa extract to rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract of 1.5 g/kg (DWE = 8.0 g/kg) by intraperitoneal injection. After 
different period of time, serum was collected for the enzyme measurement. 
Data are expressed as mean 土 S.E. 
* Significantly different when compared with the saline control group, 
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Figure A4: Serum level of creatine kinase (CK) at different time after i.p. injection 
of Mimosa extract to rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract of 1.5 g/kg (DWE = 8.0 g/kg) by intraperitoneal injection. After 
different period of time, serum was collected for the enzyme measurement. 
Data are expressed as mean 土 S.E. 
* Significantly different when compared with the saline control group, 
P < 0 . 0 5 . 
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Figure A5: Serum level of glutamic oxalacetic transaminase (GOT) at different time 
after i.p. injection of Mimosa extract to rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract of 1.5 g/kg (DWE 二 8.0 g/kg) by intraperitoneal injection. After 
different period of time, serum was collected for the enzyme measurement. 
Data are expressed as mean 士 S.E. 
* Significantly different when compared with the saline control group, 
P < 0 . 0 5 . 
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Figure A6: Serum level of glutamic pyruvic transaminase (GPT) at different time 
after i.p. injection of Mimosa extract to rats. 
Sprague-Dawley rats were given a single dose of either saline or Mimosa 
extract of 1.5 g/kg (DWE == 8.0 g/kg) by intraperitoneal injection. After 
different period of time, serum was collected for the enzyme measurement. 
Data are expressed as mean 土 S.E. 
* Significantly different when compared with the saline control group, 
P < 0 . 0 5 . 
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